Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nuclear receptor activity	NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A AR NR1I3	1.89e-28	60	56	16	GO:0004879
GeneOntologyMolecularFunction	ligand-activated transcription factor activity	NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A AR NR1I3	2.56e-28	61	56	16	GO:0098531
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	NR2C1 NR2C2 ZNF671 SALL2 THRA SALL1 THRB RARG FEZF2 ZNF337 ZNF341 FEZF1 ZNF875 ZNF516 NR4A2 IRF8 SP5 NR4A3 ZNF264 RORA NR1H2 RORC NR3C2 ZNF615 ZNF224 ZNF226 NR4A1 PPARG ZNF606 HNF4A ZNF614 AR ZFP82 NR1I3	7.14e-25	1459	56	34	GO:0000977
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	NR2C1 NR2C2 SALL2 THRA SALL1 THRB RARG FEZF2 ZNF337 ZNF341 FEZF1 ZNF875 ZNF516 NR4A2 IRF8 SP5 NR4A3 ZNF264 RORA NR1H2 RORC NR3C2 ZNF615 ZNF224 ZNF226 NR4A1 PPARG ZNF606 HNF4A ZNF614 AR ZFP82 NR1I3	4.87e-24	1412	56	33	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	NR2C1 NR2C2 ZNF671 SALL2 THRA SALL1 THRB RARG FEZF2 ZNF341 FEZF1 ZNF516 NR4A2 IRF8 SP5 NR4A3 ZNF264 RORA NR1H2 RORC NR3C2 ZNF615 ZNF224 ZNF226 NR4A1 PPARG ZNF606 HNF4A AR ZFP82 NR1I3	3.65e-23	1244	56	31	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	NR2C1 NR2C2 ZNF671 SALL2 THRA SALL1 THRB RARG FEZF2 ZNF341 FEZF1 ZNF516 NR4A2 IRF8 SP5 NR4A3 ZNF264 RORA NR1H2 RORC NR3C2 ZNF615 ZNF224 ZNF226 NR4A1 PPARG ZNF606 HNF4A AR ZFP82 NR1I3	6.91e-23	1271	56	31	GO:0000987
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	NR2C2 SALL2 FEZF2 ZNF341 NR4A2 NR4A3 NR1H2 ZNF615 ZNF224 ZNF226 NR4A1 PPARG ZNF606 HNF4A AR NR1I3	2.05e-12	566	56	16	GO:0001216
GeneOntologyMolecularFunction	zinc ion binding	NR2C1 NR2C2 THRA THRB RARG ZNF875 NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 HERC2 PPARG HNF4A AR NR1I3	1.78e-11	891	56	18	GO:0008270
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	NR2C2 SALL2 FEZF2 NR4A2 NR4A3 NR1H2 ZNF615 ZNF224 ZNF226 NR4A1 PPARG ZNF606 HNF4A AR NR1I3	2.44e-11	560	56	15	GO:0001228
GeneOntologyMolecularFunction	transcription factor binding	PHF1 THRA SALL1 THRB RARG ZNF516 NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A AR	1.45e-10	753	56	16	GO:0008134
GeneOntologyMolecularFunction	transcription coactivator binding	THRB NR4A3 RORA RORC NR3C2 PPARG AR	1.48e-10	54	56	7	GO:0001223
GeneOntologyMolecularFunction	transcription coregulator binding	PHF1 THRB NR4A3 RORA RORC NR3C2 PPARG HNF4A AR	1.81e-10	140	56	9	GO:0001221
GeneOntologyMolecularFunction	transition metal ion binding	NR2C1 NR2C2 THRA THRB RARG ZNF875 NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 LOXL3 NR4A1 HERC2 PPARG HNF4A AR NR1I3	2.35e-10	1189	56	19	GO:0046914
GeneOntologyMolecularFunction	DNA-binding transcription repressor activity, RNA polymerase II-specific	NR2C1 SALL1 FEZF2 FEZF1 IRF8 SP5 RORC ZNF224 PPARG	2.44e-07	320	56	9	GO:0001227
GeneOntologyMolecularFunction	DNA-binding transcription repressor activity	NR2C1 SALL1 FEZF2 FEZF1 IRF8 SP5 RORC ZNF224 PPARG	2.85e-07	326	56	9	GO:0001217
GeneOntologyMolecularFunction	nuclear retinoid X receptor binding	RARG NR4A2 NR1H2 PPARG	4.72e-07	23	56	4	GO:0046965
GeneOntologyMolecularFunction	nuclear receptor binding	RARG NR4A2 NR4A3 NR1H2 NR4A1 PPARG AR	8.89e-07	187	56	7	GO:0016922
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	SALL1 RARG NR4A2 NR4A3 NR1H2 NR4A1 PPARG HNF4A AR	2.20e-06	417	56	9	GO:0061629
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	SALL1 RARG ZNF516 NR4A2 NR4A3 NR1H2 NR4A1 PPARG HNF4A AR	4.36e-06	582	56	10	GO:0140297
GeneOntologyMolecularFunction	nuclear retinoic acid receptor binding	RARG NR4A2 NR1H2 PPARG	1.70e-05	55	56	4	GO:0042974
GeneOntologyMolecularFunction	nuclear glucocorticoid receptor binding	NR4A2 NR4A3 NR4A1	2.30e-05	20	56	3	GO:0035259
GeneOntologyMolecularFunction	chromatin binding	PHF1 THRA SALL1 THRB RARG FEZF2 NR1H2 PPARG HNF4A AR	3.46e-05	739	56	10	GO:0003682
GeneOntologyMolecularFunction	nuclear steroid receptor activity	NR2C1 NR4A3 NR3C2	4.60e-05	25	56	3	GO:0003707
GeneOntologyMolecularFunction	pre-mRNA 3'-splice site binding	ZRSR2P1 ZRSR2	1.61e-04	7	56	2	GO:0030628
GeneOntologyMolecularFunction	thyroid hormone binding	THRA THRB	1.61e-04	7	56	2	GO:0070324
GeneOntologyMolecularFunction	beta-catenin binding	SALL1 NR4A2 RORA AR	3.58e-04	120	56	4	GO:0008013
GeneOntologyMolecularFunction	estrogen response element binding	NR3C2 AR	4.18e-04	11	56	2	GO:0034056
GeneOntologyMolecularFunction	steroid binding	RORA RORC NR3C2 AR	5.28e-04	133	56	4	GO:0005496
GeneOntologyMolecularFunction	transcription corepressor binding	PHF1 RORA HNF4A	6.08e-04	59	56	3	GO:0001222
GeneOntologyMolecularFunction	general transcription initiation factor binding	THRA NR3C2 AR	7.71e-04	64	56	3	GO:0140296
GeneOntologyMolecularFunction	arachidonate binding	PPARG HNF4A	7.92e-04	15	56	2	GO:0050544
GeneOntologyMolecularFunction	oxysterol binding	RORA RORC	9.04e-04	16	56	2	GO:0008142
GeneOntologyMolecularFunction	icosanoid binding	PPARG HNF4A	9.04e-04	16	56	2	GO:0050542
GeneOntologyMolecularFunction	icosatetraenoic acid binding	PPARG HNF4A	9.04e-04	16	56	2	GO:0050543
GeneOntologyMolecularFunction	R-SMAD binding	PPARG ZC3H3	2.40e-03	26	56	2	GO:0070412
GeneOntologyMolecularFunction	long-chain fatty acid binding	PPARG HNF4A	2.79e-03	28	56	2	GO:0036041
GeneOntologyMolecularFunction	histone acetyltransferase binding	NR4A3 NR3C2	2.99e-03	29	56	2	GO:0035035
GeneOntologyMolecularFunction	hormone binding	THRA THRB AR	3.03e-03	103	56	3	GO:0042562
GeneOntologyMolecularFunction	TBP-class protein binding	THRA NR3C2	3.86e-03	33	56	2	GO:0017025
GeneOntologyBiologicalProcess	intracellular receptor signaling pathway	NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A AR NR1I3	1.12e-14	416	56	16	GO:0030522
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	NR2C2 SALL2 THRA SALL1 THRB RARG FEZF2 NR4A2 IRF8 NR4A3 RORA NR1H2 NR3C2 ZNF615 ZNF224 ZNF226 NR4A1 PPARG ZNF606 HNF4A AR ACTR2 NR1I3	3.50e-13	1390	56	23	GO:0045944
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	NR2C1 NR2C2 SALL2 THRA SALL1 THRB RARG FEZF2 FEZF1 NR4A2 IRF8 SP5 NR4A3 NR1H2 RORC ZNF224 PPARG AR NR1I3	1.70e-11	1053	56	19	GO:0000122
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	NR2C1 NR2C2 SALL2 THRA SALL1 THRB RARG FEZF2 FEZF1 NR4A2 IRF8 SP5 NR4A3 NR1H2 RORC LOXL3 ZNF224 PPARG HNF4A AR NR1I3	3.36e-11	1399	56	21	GO:0045892
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	NR2C1 NR2C2 SALL2 THRA SALL1 THRB RARG FEZF2 FEZF1 NR4A2 IRF8 SP5 NR4A3 NR1H2 RORC LOXL3 ZNF224 PPARG HNF4A AR NR1I3	4.05e-11	1413	56	21	GO:1902679
GeneOntologyBiologicalProcess	retinoic acid receptor signaling pathway	NR2C1 THRA THRB RARG NR1H2 PPARG	7.85e-10	38	56	6	GO:0048384
GeneOntologyBiologicalProcess	hormone-mediated signaling pathway	NR2C1 THRA THRB RARG NR4A3 NR1H2 NR3C2 PPARG AR	1.83e-08	244	56	9	GO:0009755
GeneOntologyBiologicalProcess	nuclear receptor-mediated signaling pathway	NR2C1 THRA THRB RARG NR1H2 NR3C2 PPARG AR	6.99e-08	202	56	8	GO:0141193
GeneOntologyBiologicalProcess	cellular response to corticotropin-releasing hormone stimulus	NR4A2 NR4A3 NR4A1	3.77e-07	6	56	3	GO:0071376
GeneOntologyBiologicalProcess	response to corticotropin-releasing hormone	NR4A2 NR4A3 NR4A1	3.77e-07	6	56	3	GO:0043435
GeneOntologyBiologicalProcess	courtship behavior	THRA THRB AR	6.58e-07	7	56	3	GO:0007619
GeneOntologyBiologicalProcess	cellular response to hormone stimulus	NR2C1 THRA THRB RARG NR4A2 NR4A3 NR1H2 NR3C2 NR4A1 PPARG AR	3.39e-06	727	56	11	GO:0032870
GeneOntologyBiologicalProcess	mRNA transcription by RNA polymerase II	THRA THRB NR1H2 PPARG	1.20e-05	52	56	4	GO:0042789
GeneOntologyBiologicalProcess	fat cell differentiation	ZNF516 NR4A2 NR4A3 RORA RORC NR4A1 PPARG	1.33e-05	291	56	7	GO:0045444
GeneOntologyBiologicalProcess	mRNA transcription	THRA THRB NR1H2 PPARG	1.73e-05	57	56	4	GO:0009299
GeneOntologyBiologicalProcess	female courtship behavior	THRA THRB	2.17e-05	3	56	2	GO:0008050
GeneOntologyBiologicalProcess	positive regulation of thyroid hormone receptor signaling pathway	THRA THRB	2.17e-05	3	56	2	GO:0002157
GeneOntologyBiologicalProcess	forebrain anterior/posterior pattern specification	FEZF2 FEZF1	4.33e-05	4	56	2	GO:0021797
GeneOntologyBiologicalProcess	response to hormone	NR2C1 THRA THRB RARG NR4A2 NR4A3 NR1H2 NR3C2 NR4A1 PPARG AR	9.52e-05	1042	56	11	GO:0009725
GeneOntologyBiologicalProcess	regulation of lipid metabolic process	THRA THRB RORA NR1H2 RORC PPARG HNF4A	1.26e-04	415	56	7	GO:0019216
GeneOntologyBiologicalProcess	cellular response to lipid	NR2C1 NR2C2 RARG IRF8 NR4A3 RORA RORC NR3C2 AR	1.70e-04	748	56	9	GO:0071396
GeneOntologyBiologicalProcess	response to lipid	NR2C1 NR2C2 RARG IRF8 NR4A3 RORA RORC NR3C2 NR4A1 PPARG AR	1.89e-04	1126	56	11	GO:0033993
GeneOntologyBiologicalProcess	negative regulation of response to type II interferon	NR1H2 PPARG	2.01e-04	8	56	2	GO:0060331
GeneOntologyBiologicalProcess	negative regulation of type II interferon-mediated signaling pathway	NR1H2 PPARG	2.01e-04	8	56	2	GO:0060336
GeneOntologyBiologicalProcess	regulation of thyroid hormone receptor signaling pathway	THRA THRB	2.01e-04	8	56	2	GO:0002155
GeneOntologyBiologicalProcess	cellular response to organic cyclic compound	NR2C1 SP5 NR4A3 RORA RORC NR3C2 PPARG AR	2.15e-04	605	56	8	GO:0071407
GeneOntologyBiologicalProcess	regulation of female receptivity	THRA THRB	2.57e-04	9	56	2	GO:0045924
GeneOntologyBiologicalProcess	thyroid hormone receptor signaling pathway	THRA THRB	2.57e-04	9	56	2	GO:0002154
GeneOntologyBiologicalProcess	cellular response to type II interferon	IRF8 NR1H2 PPARG ACTR2	2.60e-04	114	56	4	GO:0071346
GeneOntologyBiologicalProcess	T-helper 17 cell differentiation	RORA RORC LOXL3	2.82e-04	47	56	3	GO:0072539
GeneOntologyBiologicalProcess	neuron projection morphogenesis	CACNG7 FEZF2 FEZF1 CAMK2B MATN2 NR4A2 FSTL4 NR4A3 ACTR2	2.85e-04	802	56	9	GO:0048812
GeneOntologyBiologicalProcess	neuron migration	FEZF2 FEZF1 CAMK2B MATN2 NR4A2	3.10e-04	218	56	5	GO:0001764
GeneOntologyBiologicalProcess	type I pneumocyte differentiation	THRA THRB	3.21e-04	10	56	2	GO:0060509
GeneOntologyBiologicalProcess	connective tissue development	THRA THRB RARG ZNF516 RORC PPARG	3.26e-04	343	56	6	GO:0061448
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	CACNG7 FEZF2 FEZF1 CAMK2B MATN2 NR4A2 FSTL4 NR4A3 ACTR2	3.33e-04	819	56	9	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	CACNG7 FEZF2 FEZF1 CAMK2B MATN2 NR4A2 FSTL4 NR4A3 ACTR2	3.54e-04	826	56	9	GO:0048858
GeneOntologyBiologicalProcess	positive regulation of fatty acid metabolic process	NR1H2 PPARG HNF4A	3.60e-04	51	56	3	GO:0045923
GeneOntologyBiologicalProcess	female mating behavior	THRA THRB	4.70e-04	12	56	2	GO:0060180
GeneOntologyBiologicalProcess	negative regulation of cholesterol storage	NR1H2 PPARG	4.70e-04	12	56	2	GO:0010887
GeneOntologyBiologicalProcess	regulation of circadian rhythm	RORA RORC PPARG HNF4A	4.95e-04	135	56	4	GO:0042752
GeneOntologyBiologicalProcess	mating behavior	THRA THRB AR	5.00e-04	57	56	3	GO:0007617
GeneOntologyBiologicalProcess	response to type II interferon	IRF8 NR1H2 PPARG ACTR2	5.83e-04	141	56	4	GO:0034341
GeneOntologyBiologicalProcess	positive regulation of miRNA transcription	NR1H2 PPARG AR	6.10e-04	61	56	3	GO:1902895
GeneOntologyBiologicalProcess	T-helper 17 type immune response	RORA RORC LOXL3	7.02e-04	64	56	3	GO:0072538
GeneOntologyBiologicalProcess	negative regulation of macrophage derived foam cell differentiation	NR1H2 PPARG	7.43e-04	15	56	2	GO:0010745
GeneOntologyBiologicalProcess	cell dedifferentiation	FEZF2 FEZF1	7.43e-04	15	56	2	GO:0043697
GeneOntologyBiologicalProcess	dedifferentiation	FEZF2 FEZF1	7.43e-04	15	56	2	GO:0043696
GeneOntologyBiologicalProcess	regulation of response to type II interferon	NR1H2 PPARG	7.43e-04	15	56	2	GO:0060330
GeneOntologyBiologicalProcess	regulation of type II interferon-mediated signaling pathway	NR1H2 PPARG	7.43e-04	15	56	2	GO:0060334
GeneOntologyBiologicalProcess	regulation of system process	CACNG7 THRA THRB CAMK2B NR4A3 NR1H2 NR4A1 PPARG	7.76e-04	734	56	8	GO:0044057
GeneOntologyBiologicalProcess	steroid hormone receptor signaling pathway	NR2C1 NR4A3 NR3C2 AR	8.32e-04	155	56	4	GO:0043401
GeneOntologyBiologicalProcess	cold-induced thermogenesis	THRA ZNF516 NR1H2 PPARG	8.52e-04	156	56	4	GO:0106106
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	FEZF2 FEZF1 CAMK2B MATN2 NR4A2 FSTL4 NR4A3 ACTR2	8.78e-04	748	56	8	GO:0048667
GeneOntologyBiologicalProcess	interneuron migration	FEZF2 FEZF1	9.59e-04	17	56	2	GO:1904936
GeneOntologyBiologicalProcess	muscle adaptation	CAMK2B NR4A3 PPARG AR	1.03e-03	164	56	4	GO:0043500
GeneOntologyBiologicalProcess	positive regulation of miRNA metabolic process	NR1H2 PPARG AR	1.03e-03	73	56	3	GO:2000630
GeneOntologyBiologicalProcess	striated muscle adaptation	CAMK2B PPARG AR	1.03e-03	73	56	3	GO:0014888
GeneOntologyBiologicalProcess	reproductive behavior	THRA THRB AR	1.07e-03	74	56	3	GO:0019098
GeneOntologyBiologicalProcess	regulation of small molecule metabolic process	THRB RORA NR1H2 RORC PPARG HNF4A	1.12e-03	434	56	6	GO:0062012
GeneOntologyBiologicalProcess	tube development	SALL2 THRA SALL1 THRB RARG NR4A3 RORA LOXL3 NR4A1 PPARG AR	1.20e-03	1402	56	11	GO:0035295
GeneOntologyBiologicalProcess	cell morphogenesis	CACNG7 FEZF2 FEZF1 CAMK2B MATN2 NR4A2 FSTL4 NR4A3 AR ACTR2	1.27e-03	1194	56	10	GO:0000902
GeneOntologyBiologicalProcess	adipose tissue development	ZNF516 RORC PPARG	1.30e-03	79	56	3	GO:0060612
GeneOntologyBiologicalProcess	adaptive thermogenesis	THRA ZNF516 NR1H2 PPARG	1.33e-03	176	56	4	GO:1990845
GeneOntologyBiologicalProcess	regulation of cholesterol storage	NR1H2 PPARG	1.33e-03	20	56	2	GO:0010885
GeneOntologyBiologicalProcess	regulation of nervous system development	RARG FEZF2 FEZF1 CAMK2B FSTL4 PPARG ACTR2	1.45e-03	625	56	7	GO:0051960
GeneOntologyBiologicalProcess	regulation of type B pancreatic cell proliferation	NR4A3 NR4A1	1.47e-03	21	56	2	GO:0061469
GeneOntologyBiologicalProcess	regulation of miRNA transcription	NR1H2 PPARG AR	1.49e-03	83	56	3	GO:1902893
GeneOntologyBiologicalProcess	miRNA transcription	NR1H2 PPARG AR	1.55e-03	84	56	3	GO:0061614
GeneOntologyBiologicalProcess	cellular response to oxygen-containing compound	NR2C2 RARG NR4A2 IRF8 NR4A3 RORA RORC NR3C2 NR4A1 PPARG AR	1.57e-03	1450	56	11	GO:1901701
GeneOntologyCellularComponent	chromatin	BNC2 NR2C1 NR2C2 THRA SALL1 THRB RARG NR4A2 IRF8 SP5 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A AR NR1I3	5.88e-10	1480	56	20	GO:0000785
GeneOntologyCellularComponent	transcription regulator complex	THRA SALL1 THRB RARG NR4A2 NR4A3 NR1H2 ZNF224 NR4A1 PPARG	3.60e-06	596	56	10	GO:0005667
GeneOntologyCellularComponent	U2AF complex	ZRSR2P1 ZRSR2	1.47e-04	7	56	2	GO:0089701
HumanPheno	Impaired sensitivity to thyroid hormone	THRA THRB	1.62e-05	2	21	2	HP:0002930
MousePheno	increased activity of thyroid gland	THRA THRB	2.39e-05	3	40	2	MP:0003502
MousePheno	abnormal fontanelle morphology	BNC2 THRA THRB	3.69e-05	23	40	3	MP:0000084
MousePheno	abnormal muscle cell glucose uptake	THRA THRB NR1H2 PPARG	3.87e-05	67	40	4	MP:0004130
Domain	zf-C4	NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A AR NR1I3	3.73e-30	46	56	16	PF00105
Domain	NUCLEAR_REC_DBD_1	NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A AR NR1I3	3.73e-30	46	56	16	PS00031
Domain	Znf_hrmn_rcpt	NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A AR NR1I3	3.73e-30	46	56	16	IPR001628
Domain	ZnF_C4	NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A AR NR1I3	3.73e-30	46	56	16	SM00399
Domain	NUCLEAR_REC_DBD_2	NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A AR NR1I3	3.73e-30	46	56	16	PS51030
Domain	-	NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A AR NR1I3	5.65e-30	47	56	16	1.10.565.10
Domain	HOLI	NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A AR NR1I3	8.46e-30	48	56	16	SM00430
Domain	Nucl_hrmn_rcpt_lig-bd	NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A AR NR1I3	8.46e-30	48	56	16	IPR000536
Domain	Hormone_recep	NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A AR NR1I3	8.46e-30	48	56	16	PF00104
Domain	-	NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A AR NR1I3	2.13e-28	57	56	16	3.30.50.10
Domain	Znf_NHR/GATA	NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A AR NR1I3	2.94e-28	58	56	16	IPR013088
Domain	Nuclear_hrmn_rcpt	NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR4A1 PPARG HNF4A NR1I3	1.81e-25	46	56	14	IPR001723
Domain	ZINC_FINGER_C2H2_2	ZXDC BNC2 ZNF671 SALL2 SALL1 ZNF234 FEZF2 ZNF337 ZNF341 FEZF1 ZNF875 ZNF516 SP5 ZNF264 ZNF615 ZNF224 ZNF226 ZNF606 ZNF614 ZFP82	3.45e-14	775	56	20	PS50157
Domain	ZINC_FINGER_C2H2_1	ZXDC BNC2 ZNF671 SALL2 SALL1 ZNF234 FEZF2 ZNF337 ZNF341 FEZF1 ZNF875 ZNF516 SP5 ZNF264 ZNF615 ZNF224 ZNF226 ZNF606 ZNF614 ZFP82	3.62e-14	777	56	20	PS00028
Domain	-	ZXDC ZNF671 SALL2 SALL1 ZNF234 FEZF2 ZNF337 ZNF341 FEZF1 ZNF875 ZNF516 SP5 ZNF264 ZNF615 ZNF224 ZNF226 ZNF606 ZNF614 ZFP82	4.20e-14	679	56	19	3.30.160.60
Domain	Znf_C2H2-like	ZXDC BNC2 ZNF671 SALL2 SALL1 ZNF234 FEZF2 ZNF337 ZNF341 FEZF1 ZNF875 ZNF516 SP5 ZNF264 ZNF615 ZNF224 ZNF226 ZNF606 ZNF614 ZFP82	5.70e-14	796	56	20	IPR015880
Domain	zf-C2H2	BNC2 ZNF671 SALL2 SALL1 ZNF234 FEZF2 ZNF337 ZNF341 FEZF1 ZNF875 ZNF516 SP5 ZNF264 ZNF615 ZNF224 ZNF226 ZNF606 ZNF614 ZFP82	6.06e-14	693	56	19	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZXDC ZNF671 SALL2 SALL1 ZNF234 FEZF2 ZNF337 ZNF341 FEZF1 ZNF875 ZNF516 SP5 ZNF264 ZNF615 ZNF224 ZNF226 ZNF606 ZNF614 ZFP82	6.22e-14	694	56	19	IPR013087
Domain	Znf_C2H2	ZXDC BNC2 ZNF671 SALL2 SALL1 ZNF234 FEZF2 ZNF337 ZNF341 FEZF1 ZNF875 ZNF516 SP5 ZNF264 ZNF615 ZNF224 ZNF226 ZNF606 ZNF614 ZFP82	7.03e-14	805	56	20	IPR007087
Domain	ZnF_C2H2	ZXDC BNC2 ZNF671 SALL2 SALL1 ZNF234 FEZF2 ZNF337 ZNF341 FEZF1 ZNF875 ZNF516 SP5 ZNF264 ZNF615 ZNF224 ZNF226 ZNF606 ZNF614 ZFP82	7.54e-14	808	56	20	SM00355
Domain	VitD_rcpt	NR2C1 NR2C2 NR1H2 NR3C2 NR1I3	3.96e-10	14	56	5	IPR000324
Domain	KRAB	ZNF671 ZNF234 ZNF337 ZNF875 ZNF264 ZNF615 ZNF224 ZNF226 ZNF606 ZNF614 ZFP82	7.58e-09	358	56	11	PS50805
Domain	KRAB	ZNF671 ZNF234 ZNF337 ZNF875 ZNF264 ZNF615 ZNF224 ZNF226 ZNF606 ZNF614 ZFP82	7.58e-09	358	56	11	PF01352
Domain	KRAB	ZNF671 ZNF234 ZNF337 ZNF875 ZNF264 ZNF615 ZNF224 ZNF226 ZNF606 ZNF614 ZFP82	1.04e-08	369	56	11	SM00349
Domain	KRAB	ZNF671 ZNF234 ZNF337 ZNF875 ZNF264 ZNF615 ZNF224 ZNF226 ZNF606 ZNF614 ZFP82	1.07e-08	370	56	11	IPR001909
Domain	Nuc_orph_rcpt	NR4A2 NR4A3 NR4A1	2.55e-08	3	56	3	IPR003070
Domain	ThyrH_rcpt	THRA THRB NR1I3	2.54e-07	5	56	3	IPR001728
Domain	zf-C2H2_6	ZNF671 SALL2 ZNF234 FEZF2 FEZF1 ZNF615 ZNF224 ZNF606 ZFP82	3.62e-07	314	56	9	PF13912
Domain	ROR_rcpt	RORA RORC	2.64e-05	3	56	2	IPR003079
Domain	U2AF_small	ZRSR2P1 ZRSR2	8.78e-05	5	56	2	IPR009145
Domain	ZnF_C3H1	ZRSR2P1 ZRSR2 ZC3H3	4.01e-04	48	56	3	SM00356
Domain	zf-CCCH	ZRSR2P1 ZRSR2 ZC3H3	4.27e-04	49	56	3	PF00642
Domain	Znf_CCCH	ZRSR2P1 ZRSR2 ZC3H3	7.01e-04	58	56	3	IPR000571
Domain	-	ZRSR2 ZC3H3	6.40e-03	40	56	2	4.10.1000.10
Pathway	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A AR NR1I3	3.19e-29	53	43	16	M8276
Pathway	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 HNF4A AR NR1I3	1.19e-27	48	43	15	MM14987
Pathway	WP_NUCLEAR_RECEPTORS	NR2C2 THRA THRB RARG NR4A2 RORA NR1H2 RORC NR4A1 PPARG HNF4A AR NR1I3	1.36e-24	38	43	13	M39657
Pathway	WP_NUCLEAR_RECEPTORS	NR2C2 THRA THRB RARG NR4A2 RORA NR1H2 RORC NR4A1 PPARG HNF4A AR NR1I3	1.36e-24	38	43	13	MM15865
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	NR2C1 NR2C2 ZNF671 THRA ZNF234 THRB RARG ZNF337 ZNF875 CAMK2B NR4A2 NR4A3 ZNF264 RORA NR1H2 RORC NR3C2 ZNF615 ZNF224 ZNF226 NR4A1 PPARG ZNF606 HNF4A ZNF614 AR NR1I3	2.84e-17	1387	43	27	M734
Pathway	REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS	NR2C1 THRA THRB NR4A2 RORA NR1H2 NR3C2 PPARG AR	1.28e-16	30	43	9	M27323
Pathway	REACTOME_SUMOYLATION	NR2C1 THRA THRB NR4A2 RORA NR1H2 NR3C2 HERC2 PPARG SMC5 AR	7.44e-12	189	43	11	M27214
Pathway	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY	NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 ZNF226 NR4A1 ZNF606 HNF4A AR NR1I3	3.05e-11	768	43	17	MM14851
Pathway	PID_RXR_VDR_PATHWAY	THRA THRB RARG NR1H2 NR4A1 PPARG	1.23e-10	26	43	6	M162
Pathway	REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS	THRA THRB RORA NR1H2 NR3C2 AR	2.01e-10	28	43	6	MM15042
Pathway	REACTOME_GENE_EXPRESSION_TRANSCRIPTION	PHF1 NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 ZNF226 NR4A1 ZNF606 HNF4A AR NR1I3	2.83e-10	1022	43	18	MM15436
Pathway	REACTOME_SUMOYLATION	THRA THRB RORA NR1H2 NR3C2 HERC2 SMC5 AR	3.67e-08	169	43	8	MM14919
Pathway	WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY	RARG PPARG NR1I3	1.01e-04	30	43	3	MM15866
Pathway	BIOCARTA_NUCLEARRS_PATHWAY	RARG PPARG NR1I3	1.35e-04	33	43	3	MM1448
Pathway	BIOCARTA_NUCLEARRS_PATHWAY	RARG PPARG NR1I3	1.48e-04	34	43	3	M16393
Pathway	WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY	RARG PPARG NR1I3	1.62e-04	35	43	3	M39488
Pathway	WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS	THRA THRB ZNF516 PPARG	1.80e-04	93	43	4	M39791
Pathway	KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY	THRA THRB	3.23e-04	9	43	2	M47629
Pathway	BIOCARTA_EGFR_SMRTE_PATHWAY	THRA THRB	4.91e-04	11	43	2	MM1432
Pathway	BIOCARTA_EGFR_SMRTE_PATHWAY	THRA THRB	4.91e-04	11	43	2	M18837
Pathway	PID_AR_TF_PATHWAY	NR2C1 NR2C2 AR	5.57e-04	53	43	3	M151
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	NR2C1 THRA THRB NR4A2 ADAMTS18 RORA NR1H2 NR3C2 HERC2 PPARG SMC5 AR	1.15e-03	1475	43	12	M19806
Pubmed	Automated yeast two-hybrid screening for nuclear receptor-interacting proteins.	ZXDC NR2C2 THRA THRB RARG CAMK2B NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 PPARG HNF4A AR NR1I3	3.01e-26	133	56	16	15604093
Pubmed	A dynamic expression survey identifies transcription factors relevant in mouse digestive tract development.	NR2C1 THRB RARG NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A AR NR1I3	6.68e-21	118	56	13	16971476
Pubmed	A census of human transcription factors: function, expression and evolution.	NR2C1 NR2C2 SALL2 THRA SALL1 THRB RARG NR4A2 IRF8 SP5 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A ZC3H3 AR NR1I3	2.56e-19	908	56	21	19274049
Pubmed	Screening large numbers of expression patterns of transcription factors in late stages of the mouse thymus.	NR2C1 THRA RARG NR4A2 IRF8 NR4A3 NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A NR1I3	2.78e-16	263	56	13	20932939
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	PHF1 ZXDC NR2C1 SALL2 THRA RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 ZNF226 NR4A1 HNF4A NR1I3	1.47e-14	709	56	16	22988430
Pubmed	Nuclear receptors in Leydig cell gene expression and function.	NR2C1 RARG NR4A3 NR1H2 NR4A1 AR	9.67e-13	22	56	6	20375256
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	NR2C1 NR2C2 THRB RARG NR4A2 IRF8 RORC NR3C2 NR4A1 HNF4A NR1I3	9.78e-10	544	56	11	28473536
Pubmed	Interaction of nuclear receptor zinc finger DNA binding domains with histone deacetylase.	NR2C1 NR2C2 PPARG AR	1.97e-09	11	56	4	12943985
Pubmed	Regulation and binding of pregnane X receptor by nuclear receptor corepressor silencing mediator of retinoid and thyroid hormone receptors (SMRT).	THRA NR1H2 PPARG NR1I3	2.95e-09	12	56	4	16219912
Pubmed	NR4A nuclear receptors support memory enhancement by histone deacetylase inhibitors.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	22996661
Pubmed	Inhibition of adipocyte differentiation by Nur77, Nurr1, and Nor1.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	18945812
Pubmed	Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	15964844
Pubmed	Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	10523643
Pubmed	Orphan nuclear receptors in T lymphocyte development.	NR4A3 RORC NR4A1	3.95e-09	3	56	3	12223510
Pubmed	Replicated association of the NR4A3 gene with smoking behaviour in schizophrenia and in bipolar disorder.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	20659174
Pubmed	Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c+ Dendritic Cell Dysregulation in Systemic Sclerosis.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	36482877
Pubmed	NR4A transcription factors limit CAR T cell function in solid tumours.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	30814732
Pubmed	The NR4A orphan nuclear receptors: mediators in metabolism and diseases.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	25089663
Pubmed	Beta-adrenergic signaling regulates NR4A nuclear receptor and metabolic gene expression in multiple tissues.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	19465082
Pubmed	MSKs are required for the transcription of the nuclear orphan receptors Nur77, Nurr1 and Nor1 downstream of MAPK signalling.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	15910281
Pubmed	Nuclear receptors of the NR4a family are not required for the development and function of follicular T helper cells.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	25899083
Pubmed	Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	27159982
Pubmed	The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	22143616
Pubmed	Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	16873729
Pubmed	The orphan nuclear receptor Nur77 is a determinant of myofiber size and muscle mass in mice.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	25605333
Pubmed	Relevance of the NR4A sub-family of nuclear orphan receptors in trophoblastic BeWo cell differentiation.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	28808448
Pubmed	The NR4A receptors Nurr1 and Nur77 are increased in human placenta from women with gestational diabetes.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	25199433
Pubmed	NR4A nuclear receptors in immunity and atherosclerosis.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	24005216
Pubmed	Minireview: What is Known about SUMOylation Among NR4A Family Members?	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	34437889
Pubmed	Stress and glucocorticoid regulation of NR4A genes in mice.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	24753204
Pubmed	Differential regulation of Nr4a subfamily nuclear receptors following mast cell activation.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	21621845
Pubmed	Nuclear receptor 4A (NR4A) family - orphans no more.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	25917081
Pubmed	FGF-8 stimulates the expression of NR4A orphan nuclear receptors in osteoblasts.	NR4A2 NR4A3 NR4A1	3.95e-09	3	56	3	18809462
Pubmed	Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1.	THRA NR3C2 HNF4A AR	4.26e-09	13	56	4	9115274
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	PHF1 THRA THRB NR4A3 NR1H2 RORC ZNF226 PPARG HNF4A AR ZFP82 NR1I3	1.24e-08	877	56	12	20211142
Pubmed	TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion.	NR4A2 NR4A3 NR4A1	1.58e-08	4	56	3	31152140
Pubmed	Trained immunity induced by high-salt diet impedes stroke recovery.	NR4A2 NR4A3 NR4A1	1.58e-08	4	56	3	37965920
Pubmed	Evaluation of mRNA Expressions of TOX and NR4As in CD8+ T cells in Acute Leukemia.	NR4A2 NR4A3 NR4A1	1.58e-08	4	56	3	37961948
Pubmed	Nr4a Receptors Regulate Development and Death of Labile Treg Precursors to Prevent Generation of Pathogenic Self-Reactive Cells.	NR4A2 NR4A3 NR4A1	1.58e-08	4	56	3	30089271
Pubmed	Parathyroid hormone induces the NR4A family of nuclear orphan receptors in vivo.	NR4A2 NR4A3 NR4A1	1.58e-08	4	56	3	15910753
Pubmed	Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1.	NR4A2 NR4A3 NR4A1	1.58e-08	4	56	3	14525795
Pubmed	Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis.	NR4A2 NR4A3 NR4A1	1.58e-08	4	56	3	23334790
Pubmed	Dual function of Pin1 in NR4A nuclear receptor activation: enhanced activity of NR4As and increased Nur77 protein stability.	NR4A2 NR4A3 NR4A1	1.58e-08	4	56	3	22789442
Pubmed	Regulation of peripheral Th/Treg differentiation and suppression of airway inflammation by Nr4a transcription factors.	NR4A2 NR4A3 NR4A1	1.58e-08	4	56	3	33665581
Pubmed	The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation.	NR4A2 NR4A3 NR4A1	3.94e-08	5	56	3	15155786
Pubmed	Suppression of Th2 and Tfh immune reactions by Nr4a receptors in mature T reg cells.	NR4A2 NR4A3 NR4A1	3.94e-08	5	56	3	26304965
Pubmed	Identification and characterization of RanBPM, a novel coactivator of thyroid hormone receptors.	THRA THRB AR	3.94e-08	5	56	3	16595702
Pubmed	Retinoid X receptor heterodimerization and developmental expression distinguish the orphan nuclear receptors NGFI-B, Nurr1, and Nor1.	NR4A2 NR4A3 NR4A1	3.94e-08	5	56	3	8961274
Pubmed	A signature motif mediating selective interactions of BCL11A with the NR2E/F subfamily of orphan nuclear receptors.	THRB RORA PPARG AR	4.31e-08	22	56	4	23975195
Pubmed	Estrogen receptor, a common interaction partner for a subset of nuclear receptors.	THRA THRB HNF4A	7.88e-08	6	56	3	9717844
Pubmed	NR4A receptors up-regulate the antiproteinase alpha-2 macroglobulin (A2M) and modulate MMP-2 and MMP-9 in vascular smooth muscle cells.	NR4A2 NR4A3 NR4A1	7.88e-08	6	56	3	25809189
Pubmed	RIF-1, a novel nuclear receptor corepressor that associates with the nuclear matrix.	THRB RORA PPARG	1.38e-07	7	56	3	17455211
Pubmed	Cloning and characterization of RAP250, a novel nuclear receptor coactivator.	THRA THRB PPARG	2.20e-07	8	56	3	10681503
Pubmed	Cryptochromes mediate rhythmic repression of the glucocorticoid receptor.	RORA RORC AR	2.20e-07	8	56	3	22170608
Pubmed	Thyroid Hormone-Otx2 Signaling Is Required for Embryonic Ventral Midbrain Neural Stem Cells Differentiated into Dopamine Neurons.	THRA THRB NR4A2	2.20e-07	8	56	3	25867707
Pubmed	Nur77 is phosphorylated in cells by RSK in response to mitogenic stimulation.	NR4A2 NR4A3 NR4A1	2.20e-07	8	56	3	16223362
Pubmed	Circadian repressors CRY1 and CRY2 broadly interact with nuclear receptors and modulate transcriptional activity.	HNF4A AR NR1I3	3.30e-07	9	56	3	28751364
Pubmed	The mammalian clock component PERIOD2 coordinates circadian output by interaction with nuclear receptors.	THRA NR4A2 HNF4A	3.30e-07	9	56	3	20159955
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	PHF1 ZXDC BNC2 NR2C1 THRA SALL1 ZNF516 IRF8 RORA NR1H2	5.88e-07	808	56	10	20412781
Pubmed	Two distinct nuclear receptor-interaction domains and CREB-binding protein-dependent transactivation function of activating signal cointegrator-2.	THRA THRB NR1H2	8.61e-07	12	56	3	11158331
Pubmed	TIF1beta/KAP-1 is a coactivator of the orphan nuclear receptor NGFI-B/Nur77.	NR4A2 NR4A3 NR4A1	1.77e-06	15	56	3	19321449
Pubmed	Zinc finger genes Fezf1 and Fezf2 control neuronal differentiation by repressing Hes5 expression in the forebrain.	FEZF2 FEZF1 NR4A2	2.18e-06	16	56	3	20431123
Pubmed	Nur77 deletion impairs muscle growth during developmental myogenesis and muscle regeneration in mice.	NR4A2 NR4A3 NR4A1	2.18e-06	16	56	3	28170423
Pubmed	Neurodevelopmental control by thyroid hormone receptors.	THRA THRB	2.55e-06	2	56	2	11861164
Pubmed	Fundamentally distinct roles of thyroid hormone receptor isoforms in a thyrotroph cell line are due to differential DNA binding.	THRA THRB	2.55e-06	2	56	2	22570333
Pubmed	Divergent roles for thyroid hormone receptor beta isoforms in the endocrine axis and auditory system.	THRA THRB	2.55e-06	2	56	2	10430610
Pubmed	Audiogenic seizure susceptibility in thyroid hormone receptor beta-deficient mice.	THRA THRB	2.55e-06	2	56	2	11496110
Pubmed	Retinoids induce Fas(CD95) ligand cell surface expression via RARgamma and nur77 in T cells.	RARG NR4A1	2.55e-06	2	56	2	14991612
Pubmed	Transcriptional Profiling of Monocytes Deficient in Nuclear Orphan Receptors NR4A2 and NR4A3 Reveals Distinct Signalling Roles Related to Antigen Presentation and Viral Response.	NR4A2 NR4A3	2.55e-06	2	56	2	34248958
Pubmed	dFezf/Earmuff maintains the restricted developmental potential of intermediate neural progenitors in Drosophila.	FEZF2 FEZF1	2.55e-06	2	56	2	20152183
Pubmed	Differential roles for Nr4a1 and Nr4a2 in object location vs. object recognition long-term memory.	NR4A2 NR4A1	2.55e-06	2	56	2	23161447
Pubmed	The orphan nuclear receptor Nor1/Nr4a3 is a negative regulator of β-cell mass.	NR4A3 NR4A1	2.55e-06	2	56	2	30696767
Pubmed	Thyroid hormone receptor-α deletion decreases heart function and exercise performance in apolipoprotein E-deficient mice.	THRA THRB	2.55e-06	2	56	2	26672044
Pubmed	Mutant thyroid hormone receptors (TRs) isolated from distinct cancer types display distinct target gene specificities: a unique regulatory repertoire associated with two renal clear cell carcinomas.	THRA THRB	2.55e-06	2	56	2	21622534
Pubmed	Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation.	THRA THRB	2.55e-06	2	56	2	10346821
Pubmed	Thyroid hormone receptor beta-dependent expression of a potassium conductance in inner hair cells at the onset of hearing.	THRA THRB	2.55e-06	2	56	2	9861043
Pubmed	ZRSR1 co-operates with ZRSR2 in regulating splicing of U12-type introns in murine hematopoietic cells.	ZRSR2P1 ZRSR2	2.55e-06	2	56	2	33691379
Pubmed	Nuclear receptors Nur77 and Nurr1 modulate mesenchymal stromal cell migration.	NR4A2 NR4A1	2.55e-06	2	56	2	21480782
Pubmed	NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.	NR4A3 NR4A1	2.55e-06	2	56	2	28249906
Pubmed	Retinoic Acid receptor-related orphan receptor alpha-enhanced thyroid hormone receptor-mediated transcription requires its ligand binding domain which is not, by itself, sufficient: possible direct interaction of two receptors.	THRB RORA	2.55e-06	2	56	2	19645616
Pubmed	Molecular signatures of thyroid follicular neoplasia.	NR4A3 NR4A1	2.55e-06	2	56	2	20668010
Pubmed	Comparative Phenotyping of Mice Reveals Canonical and Noncanonical Physiological Functions of TRα and TRβ.	THRA THRB	2.55e-06	2	56	2	38889231
Pubmed	Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes.	NR2C1 NR2C2	2.55e-06	2	56	2	22042865
Pubmed	Retardation of cochlear maturation and impaired hair cell function caused by deletion of all known thyroid hormone receptors.	THRA THRB	2.55e-06	2	56	2	11739587
Pubmed	Impaired hair growth and wound healing in mice lacking thyroid hormone receptors.	THRA THRB	2.55e-06	2	56	2	25254665
Pubmed	A bidirectional regulation between the TR2/TR4 orphan receptors (TR2/TR4) and the ciliary neurotrophic factor (CNTF) signaling pathway.	NR2C1 NR2C2	2.55e-06	2	56	2	9694834
Pubmed	Interference of a mutant thyroid hormone receptor alpha1 with hepatic glucose metabolism.	THRA THRB	2.55e-06	2	56	2	19282388
Pubmed	A minority of cases of acinic cell carcinoma of the salivary glands are driven by an NR4A2 rearrangement: the diagnostic utility of the assessment of NR4A2 and NR4A3 alterations in salivary gland tumors.	NR4A2 NR4A3	2.55e-06	2	56	2	36469101
Pubmed	The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms.	NR4A3 NR4A1	2.55e-06	2	56	2	25410408
Pubmed	Ontogenetic profile of the expression of thyroid hormone receptors in rat and human corpora cavernosa of the penis.	THRA THRB	2.55e-06	2	56	2	20141582
Pubmed	Peroxisome proliferator-activated receptor gamma controls prostate cancer cell growth through AR-dependent and independent mechanisms.	PPARG AR	2.55e-06	2	56	2	31769890
Pubmed	Compensatory role of thyroid hormone receptor (TR) alpha 1 in resistance to thyroid hormone: study in mice with a targeted mutation in the TR beta gene and deficient in TR alpha 1.	THRA THRB	2.55e-06	2	56	2	12750454
Pubmed	A conserved 12-amino acid motif in Sall1 recruits the nucleosome remodeling and deacetylase corepressor complex.	SALL2 SALL1	2.55e-06	2	56	2	16707490
Pubmed	Canonical and Noncanonical Contribution of Thyroid Hormone Receptor Isoforms Alpha and Beta to Cardiac Hypertrophy and Heart Rate in Male Mice.	THRA THRB	2.55e-06	2	56	2	38757582
Pubmed	Naturally Occurring Amino Acids in Helix 10 of the Thyroid Hormone Receptor Mediate Isoform-Specific TH Gene Regulation.	THRA THRB	2.55e-06	2	56	2	28911178
Pubmed	Hormone selectivity in thyroid hormone receptors.	THRA THRB	2.55e-06	2	56	2	11222741
Pubmed	Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function.	THRA THRB	2.55e-06	2	56	2	16781732
Pubmed	Lack of mutations in the thyroid hormone receptor (TR) alpha and beta genes but frequent hypermethylation of the TRbeta gene in differentiated thyroid tumors.	THRA THRB	2.55e-06	2	56	2	17911173
Pubmed	Effects of thyroid hormone receptor gene disruption on myosin isoform expression in mouse skeletal muscles.	THRA THRB	2.55e-06	2	56	2	10848522
Pubmed	Increased adipogenesis in bone marrow but decreased bone mineral density in mice devoid of thyroid hormone receptors.	THRA THRB	2.55e-06	2	56	2	15780976
Interaction	NCOA1 interactions	THRA THRB RARG NR4A2 RORA NR1H2 NR3C2 NR4A1 PPARG HNF4A AR NR1I3	5.61e-15	146	56	12	int:NCOA1
Interaction	NCOR2 interactions	THRA THRB RARG CAMK2B NR4A2 NR1H2 NR4A1 PPARG SMC5 HNF4A AR WDR59 NR1I3	2.85e-13	264	56	13	int:NCOR2
Interaction	RXRG interactions	THRA THRB RARG CAMK2B NR1H2 NR4A1 PPARG NR1I3	6.10e-13	47	56	8	int:RXRG
Interaction	MED1 interactions	THRA THRB RORA NR1H2 NR4A1 HERC2 PPARG SMC5 HNF4A AR NR1I3	9.70e-12	206	56	11	int:MED1
Interaction	NR0B1 interactions	SALL1 RORA NR4A1 PPARG HNF4A AR NR1I3	1.51e-11	40	56	7	int:NR0B1
Interaction	NCOA3 interactions	PHF1 THRA THRB RARG NR1H2 RORC NR4A1 PPARG HNF4A AR NR1I3	2.40e-11	224	56	11	int:NCOA3
Interaction	NCOA2 interactions	THRA THRB RORA NR1H2 NR4A1 PPARG HNF4A AR NR1I3	1.78e-10	141	56	9	int:NCOA2
Interaction	RXRB interactions	NR2C2 THRA THRB RARG NR4A2 NR1H2 PPARG	5.95e-10	66	56	7	int:RXRB
Interaction	RXRA interactions	THRA THRB RARG NR4A2 NR1H2 NR3C2 NR4A1 PPARG NR1I3	8.95e-10	169	56	9	int:RXRA
Interaction	NRIP1 interactions	NR2C1 NR2C2 THRA THRB NR1H2 NR3C2 PPARG HNF4A AR	9.43e-10	170	56	9	int:NRIP1
Interaction	NR0B2 interactions	THRA RARG NR1H2 PPARG HNF4A AR NR1I3	3.06e-09	83	56	7	int:NR0B2
Interaction	NCOR1 interactions	NR2C1 NR2C2 THRA THRB RARG NR1H2 PPARG SMC5 HNF4A AR NR1I3	4.02e-09	363	56	11	int:NCOR1
Interaction	NCOA6 interactions	THRA THRB NR1H2 RORC PPARG SMC5 HNF4A AR	6.28e-09	145	56	8	int:NCOA6
Interaction	NSD1 interactions	THRA THRB RORA HERC2 PPARG SMC5 AR	3.82e-08	119	56	7	int:NSD1
Interaction	PNRC1 interactions	RARG RORA HNF4A AR	4.55e-07	23	56	4	int:PNRC1
Interaction	PPARGC1B interactions	THRB NR1H2 PPARG HNF4A	1.81e-06	32	56	4	int:PPARGC1B
Interaction	TBL1X interactions	THRA THRB PPARG HNF4A AR WDR59	2.27e-06	138	56	6	int:TBL1X
Interaction	HDAC3 interactions	NR2C1 NR2C2 THRA THRB PPARG HNF4A AR WDR59	2.30e-06	313	56	8	int:HDAC3
Interaction	PNRC2 interactions	RARG RORA HNF4A AR	2.63e-06	35	56	4	int:PNRC2
Interaction	PPARGC1A interactions	THRB NR4A2 PPARG HNF4A NR1I3	3.20e-06	82	56	5	int:PPARGC1A
Interaction	NR2C1 interactions	NR2C1 NR2C2 SMC5 HNF4A AR	3.61e-06	84	56	5	int:NR2C1
Interaction	SMARCA4 interactions	NR2C1 NR2C2 NR4A2 NR1H2 NR4A1 PPARG SMC5 HNF4A AR	4.71e-06	462	56	9	int:SMARCA4
Interaction	PROX1 interactions	RORA NR3C2 PPARG HNF4A	5.02e-06	41	56	4	int:PROX1
Interaction	MED14 interactions	THRA HERC2 PPARG HNF4A AR NR1I3	7.81e-06	171	56	6	int:MED14
Interaction	SMARCD3 interactions	RARG RORA NR4A1 PPARG HNF4A	1.18e-05	107	56	5	int:SMARCD3
Interaction	TRIM24 interactions	THRA ZNF264 NR3C2 PPARG SMC5 HNF4A AR NR1I3	1.34e-05	398	56	8	int:TRIM24
Interaction	TFAP2E interactions	THRB SMC5	2.27e-05	3	56	2	int:TFAP2E
Interaction	MED24 interactions	THRA PPARG HNF4A AR NR1I3	2.82e-05	128	56	5	int:MED24
Interaction	GPS2 interactions	THRA THRB PPARG HNF4A AR	4.95e-05	144	56	5	int:GPS2
Interaction	PIAS1 interactions	SALL1 NR1H2 NR3C2 NR4A1 PPARG HNF4A AR	5.29e-05	353	56	7	int:PIAS1
Interaction	PSMC5 interactions	NR2C2 THRB RARG RORA RORC NR3C2 AR NR1I3	5.39e-05	484	56	8	int:PSMC5
Interaction	BRD8 interactions	THRB PPARG SMC5 HNF4A AR	5.82e-05	149	56	5	int:BRD8
Interaction	CHD7 interactions	NR2C2 THRB SMC5 HNF4A AR	6.01e-05	150	56	5	int:CHD7
Interaction	UBN1 interactions	NR2C2 ZNF606 SMC5 HNF4A	6.22e-05	77	56	4	int:UBN1
Interaction	ZXDC interactions	ZXDC RORA NR1H2	7.05e-05	29	56	3	int:ZXDC
Interaction	ELF2 interactions	NR2C1 NR2C2 SMC5 HNF4A AR	7.24e-05	156	56	5	int:ELF2
Interaction	UBE2I interactions	THRA SALL1 THRB IRF8 NR1H2 NR3C2 PPARG HNF4A AR	7.32e-05	654	56	9	int:UBE2I
Interaction	XRCC5 interactions	PHF1 NR2C2 THRA THRB NR4A1 PPARG SMC5 AR	8.32e-05	515	56	8	int:XRCC5
Interaction	PATZ1 interactions	PHF1 NR2C2 NR4A1 HERC2 AR	8.91e-05	163	56	5	int:PATZ1
Interaction	EP300 interactions	THRA THRB RARG NR4A3 RORA RORC NR3C2 NR4A1 PPARG HNF4A AR WDR59 ACTR2	9.45e-05	1401	56	13	int:EP300
Interaction	JMJD1C interactions	THRB PPARG SMC5 AR	1.05e-04	88	56	4	int:JMJD1C
Interaction	KMT2D interactions	IRF8 HERC2 PPARG HNF4A AR	1.06e-04	169	56	5	int:KMT2D
Interaction	HDAC2 interactions	PHF1 NR2C1 NR2C2 THRA SALL1 THRB ZNF516 HERC2 SMC5 AR	1.19e-04	865	56	10	int:HDAC2
Interaction	PRMT2 interactions	SALL2 THRB ZNF341 PPARG	1.19e-04	91	56	4	int:PRMT2
Interaction	ILDR2 interactions	ARHGAP5 ZNF224 WDR59	1.25e-04	35	56	3	int:ILDR2
Interaction	SMC3 interactions	NR2C2 RORA HERC2 SMC5 HNF4A AR ACTR2	1.31e-04	408	56	7	int:SMC3
Interaction	MTA1 interactions	PHF1 NR2C1 NR2C2 SALL1 SMC5 AR	1.31e-04	283	56	6	int:MTA1
Interaction	LIN54 interactions	NR2C2 SMC5 HNF4A AR	1.35e-04	94	56	4	int:LIN54
Interaction	RREB1 interactions	NR2C2 SMC5 HNF4A AR	1.41e-04	95	56	4	int:RREB1
Interaction	DPF1 interactions	PHF1 PPARG HNF4A AR	1.41e-04	95	56	4	int:DPF1
Interaction	SAP130 interactions	PHF1 NR2C2 SMC5 HNF4A AR	1.46e-04	181	56	5	int:SAP130
Interaction	GRIP1 interactions	PHF1 THRA PPARG AR	1.47e-04	96	56	4	int:GRIP1
Interaction	SMC1A interactions	PHF1 NR2C2 THRA THRB RORA SMC5 AR	1.52e-04	418	56	7	int:SMC1A
Interaction	TRIM28 interactions	NR2C1 NR2C2 NR4A3 ZNF264 ZNF615 ZNF224 ZNF226 NR4A1 PPARG SMC5 ZNF614 AR ZFP82	1.58e-04	1474	56	13	int:TRIM28
Interaction	HIVEP1 interactions	IRF8 PPARG SMC5 HNF4A AR	1.66e-04	186	56	5	int:HIVEP1
Interaction	TBL1XR1 interactions	THRA THRB PPARG AR WDR59	1.92e-04	192	56	5	int:TBL1XR1
Interaction	ING1 interactions	SALL2 SMC5 HNF4A AR	1.93e-04	103	56	4	int:ING1
Interaction	HDAC4 interactions	ARHGAP5 NR2C1 NR2C2 NR1H2 HERC2 PPARG SMC5 HNF4A AR	1.94e-04	744	56	9	int:HDAC4
Interaction	SIAH2 interactions	THRA THRB PPARG AR	2.00e-04	104	56	4	int:SIAH2
Interaction	MIDEAS interactions	SMC5 HNF4A ZC3H3 AR	2.31e-04	108	56	4	int:MIDEAS
Interaction	TAF9B interactions	NR2C2 SMC5 HNF4A AR	2.31e-04	108	56	4	int:TAF9B
Interaction	MED17 interactions	THRA HERC2 HNF4A AR NR1I3	2.43e-04	202	56	5	int:MED17
Interaction	ZRSR2P1 interactions	ZRSR2P1 ZRSR2	2.70e-04	9	56	2	int:ZRSR2P1
Interaction	LIG3 interactions	THRA THRB PPARG SMC5 AR	2.72e-04	207	56	5	int:LIG3
Interaction	ARID3B interactions	SALL1 SMC5 HNF4A AR	2.75e-04	113	56	4	int:ARID3B
Interaction	ZBTB9 interactions	PPARG SMC5 HNF4A AR	3.14e-04	117	56	4	int:ZBTB9
Interaction	NFRKB interactions	NR2C2 SMC5 HNF4A AR	3.46e-04	120	56	4	int:NFRKB
Interaction	PAXBP1 interactions	NR2C2 HERC2 SMC5 AR	3.57e-04	121	56	4	int:PAXBP1
Interaction	ZNHIT3 interactions	THRB PPARG HNF4A	3.63e-04	50	56	3	int:ZNHIT3
Interaction	RARA interactions	NR2C1 RARG NR1H2 PPARG SMC5	3.83e-04	223	56	5	int:RARA
Interaction	NCOA4 interactions	HERC2 PPARG AR	3.85e-04	51	56	3	int:NCOA4
Interaction	SMARCA2 interactions	NR2C2 NR4A2 NR4A1 PPARG HNF4A AR	3.86e-04	346	56	6	int:SMARCA2
Interaction	U2SURP interactions	NR2C2 ZRSR2 HERC2 PPARG SMC5 AR	4.05e-04	349	56	6	int:U2SURP
Interaction	NKX3-1 interactions	RARG SP5 AR	4.08e-04	52	56	3	int:NKX3-1
Interaction	NFIX interactions	NR2C1 NR2C2 SALL1 ZNF614 AR	4.15e-04	227	56	5	int:NFIX
Interaction	RFX5 interactions	PPARG SMC5 AR	4.31e-04	53	56	3	int:RFX5
Interaction	ETV3 interactions	NR2C1 NR2C2 FSTL4 AR	4.42e-04	128	56	4	int:ETV3
Interaction	POLR1F interactions	NR2C2 HERC2 SMC5	4.56e-04	54	56	3	int:POLR1F
Interaction	PAX6 interactions	NR2C1 NR2C2 SALL1 ZNF516 AR STAC	5.20e-04	366	56	6	int:PAX6
Interaction	MGA interactions	ARHGAP5 NR4A3 SMC5 HNF4A AR	5.35e-04	240	56	5	int:MGA
Interaction	RBM27 interactions	NR2C2 SMC5 AR ACTR2	5.71e-04	137	56	4	int:RBM27
Interaction	RTCB interactions	NR2C2 MATN2 NR4A1 SMC5 AR ACTR2	5.91e-04	375	56	6	int:RTCB
Interaction	SIN3A interactions	PHF1 NR2C1 NR4A2 NR4A3 AR WDR59	6.33e-04	380	56	6	int:SIN3A
Interaction	JAZF1 interactions	NR2C1 NR2C2 PPARG	6.52e-04	61	56	3	int:JAZF1
Interaction	SMARCC1 interactions	NR2C2 NR4A1 PPARG SMC5 HNF4A AR	6.69e-04	384	56	6	int:SMARCC1
Interaction	HPS1 interactions	SALL2 SALL1	6.75e-04	14	56	2	int:HPS1
Interaction	ROBO4 interactions	THRB PPARG	6.75e-04	14	56	2	int:ROBO4
Interaction	ZNF148 interactions	NR2C2 SMC5 HNF4A AR	6.88e-04	144	56	4	int:ZNF148
Interaction	CREB1 interactions	THRA NR4A2 SMC5 AR WDR59	6.91e-04	254	56	5	int:CREB1
Interaction	EMSY interactions	NR2C2 SMC5 HNF4A AR	7.06e-04	145	56	4	int:EMSY
Interaction	KAT2B interactions	NR3C2 NR4A1 PPARG HNF4A AR	7.16e-04	256	56	5	int:KAT2B
Interaction	ZNF609 interactions	IRF8 SMC5 HNF4A AR	7.25e-04	146	56	4	int:ZNF609
Interaction	ARID5A interactions	PHF1 THRA RARG AR	7.43e-04	147	56	4	int:ARID5A
Interaction	NONO interactions	NR2C1 NR2C2 SALL1 MATN2 NR4A1 SMC5 AR	7.82e-04	549	56	7	int:NONO
Interaction	FBN2 interactions	THRB MATN2 ZNF224	7.86e-04	65	56	3	int:FBN2
Interaction	CHERP interactions	NR2C2 ZRSR2 HERC2 SMC5 AR	7.95e-04	262	56	5	int:CHERP
Interaction	VSX1 interactions	NR2C1 NR2C2 ZNF516	8.21e-04	66	56	3	int:VSX1
Interaction	HDAC1 interactions	PHF1 NR2C1 NR2C2 SALL1 FEZF2 ZNF516 RORC NR4A1 PPARG AR	8.55e-04	1108	56	10	int:HDAC1
Interaction	BICRA interactions	PPARG SMC5 HNF4A	8.58e-04	67	56	3	int:BICRA
Interaction	ARID2 interactions	PPARG SMC5 HNF4A AR	8.63e-04	153	56	4	int:ARID2
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	ZNF671 CACNG7 ZNF234 ZNF875 ZNF264 NR1H2 ZNF615 ZNF224 ZNF226 ZNF606 ZNF614 ZFP82	1.73e-08	1192	56	12	chr19q13
Cytoband	19q13.4	CACNG7 ZNF264 ZNF606	1.27e-04	79	56	3	19q13.4
Cytoband	3p25	NR2C2 PPARG	1.96e-04	17	56	2	3p25
Cytoband	12q13	RARG NR4A1	3.44e-03	71	56	2	12q13
Cytoband	19q13.12	ZNF875 ZFP82	3.54e-03	72	56	2	19q13.12
Cytoband	19q13.41	ZNF615 ZNF614	4.14e-03	78	56	2	19q13.41
GeneFamily	Nuclear hormone receptors	NR2C1 NR2C2 THRA THRB RARG NR4A2 NR4A3 RORA NR1H2 RORC NR3C2 NR4A1 PPARG HNF4A AR NR1I3	2.51e-30	49	50	16	71
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZXDC BNC2 ZNF671 SALL2 SALL1 ZNF234 FEZF2 ZNF337 ZNF341 FEZF1 ZNF875 ZNF516 SP5 ZNF264 ZNF615 ZNF224 ZNF226 ZNF606 ZNF614 ZFP82	1.13e-15	718	50	20	28
GeneFamily	Zinc fingers CCCH-type	ZRSR2P1 ZRSR2 ZC3H3	1.22e-04	35	50	3	73
Coexpression	MIKI_COEXPRESSED_WITH_CYP19A1	NR2C2 THRA HNF4A	3.21e-07	7	56	3	M1868
Coexpression	BROWNE_HCMV_INFECTION_2HR_UP	SNED1 NR4A2 NR4A3 NR4A1	1.61e-06	40	56	4	M3649
Coexpression	GSE2706_UNSTIM_VS_2H_LPS_DC_UP	ZNF671 EML5 ZNF615 ZNF224 ZNF606 ZFP82	3.97e-06	197	56	6	M4695
Coexpression	GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN	ARHGAP5 EML5 RORA RORC NR1I3	4.05e-05	179	56	5	M6689
Coexpression	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_DN	NR4A2 NR4A3 NR4A1 ZFP82 NR1I3	5.51e-05	191	56	5	M4180
Coexpression	IVANOVA_HEMATOPOIESIS_STEM_CELL	ZRSR2P1 ZRSR2 NR4A2 NR4A1 SMC5	6.23e-05	196	56	5	MM667
Coexpression	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	NR4A2 NR4A3 NR4A1	6.27e-05	36	56	3	M9162
Coexpression	GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN	PHF1 ARHGAP5 THRA RARG HERC2	6.85e-05	200	56	5	M9765
Coexpression	GSE7852_TREG_VS_TCONV_LN_UP	MATN2 ZNF516 IRF8 RORA NR3C2	6.85e-05	200	56	5	M5727
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#4_top-relative-expression-ranked_500	NR4A2 ADAMTS18 NR4A3 NR4A1 AR	2.09e-07	53	53	5	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500_k4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#1	CACNG7 SALL1 EML5 FEZF2 FEZF1 MATN2 NR4A2	8.30e-06	295	53	7	Facebase_RNAseq_e10.5_Olfactory Pit_2500_K1
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_500	BNC2 MATN2 NR4A2 TM4SF5 NR4A1	1.04e-05	116	53	5	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k3_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#1_top-relative-expression-ranked_200	ADAMTS18 NR4A3 NR4A1	2.19e-05	22	53	3	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200_k1
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_100	BNC2 NR4A2 NR4A1	5.12e-05	29	53	3	gudmap_dev gonad_e11.5_M_GonMes_Sma_k4_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_100	ADAMTS18 NR4A3 NR4A1 AR	6.60e-05	87	53	4	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_100
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#1_top-relative-expression-ranked_500	SNED1 SALL2 SALL1 RORA	7.22e-05	89	53	4	gudmap_developingKidney_e15.5_Peripheral blastema_500_k1
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_200	BNC2 MATN2 TM4SF5	7.60e-05	33	53	3	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k3_200
CoexpressionAtlas	MESO-5 amniotic fluid MSC_vs_MESO-5 blastocyst-Confounder_removed-fold2.0_adjp0.05	CACNG7 SALL2 SALL1 RARG FEZF2 FEZF1 SP5	7.69e-05	418	53	7	PCBC_ratio_MESO-5 amniotic fluid MSC_vs_MESO-5 blastocyst_cfr-2X-p05
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_500	BNC2 SALL1 NR4A2 ADAMTS18 NR4A3 NR4A1 AR	8.41e-05	424	53	7	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_100	SALL1 EML5 FEZF2 FEZF1	1.14e-04	100	53	4	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_100
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_500	BNC2 MATN2 TM4SF5 NR4A1	1.14e-04	100	53	4	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_200	BNC2 NR4A2 NR4A3	2.07e-04	46	53	3	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#2_top-relative-expression-ranked_100	NR4A3 NR4A1	3.31e-04	11	53	2	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_100_k2
ToppCell	10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	RARG MATN2 NR4A2 RORA RORC NR4A1	1.30e-07	187	56	6	f31d865ce2a21bdf64dbe29ee3e4505ab482604a
ToppCell	RA-14._Fibroblast_III\|RA / Chamber and Cluster_Paper	SNED1 BNC2 NR4A2 NR4A3 RORA NR4A1	1.38e-07	189	56	6	46e9a58aacd79db5a02898a8c7244e1884adcfd1
ToppCell	LA-14._Fibroblast_III\|LA / Chamber and Cluster_Paper	SNED1 BNC2 NR4A2 NR4A3 RORA NR4A1	1.57e-07	193	56	6	7426c291bac59e539c427bcaae18abc7d397d44e
ToppCell	mild_COVID-19-MAIT\|mild_COVID-19 / disease group, cell group and cell class (v2)	PHF1 RARG MATN2 NR4A2 RORA RORC	1.66e-07	195	56	6	b99815ec94042da1a2574468331b043d29d70b38
ToppCell	mild_COVID-19-MAIT\|World / disease group, cell group and cell class (v2)	PHF1 MATN2 NR4A2 NR4A3 RORA RORC	1.66e-07	195	56	6	74f0f709d9b3eed5d7e02a51884f02cc281782f1
ToppCell	10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-NK_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	RARG FSTL4 RORA RORC WDR59	2.51e-06	172	56	5	a126dacd94939851de1403d30f0b63eaad48bfa1
ToppCell	COVID-19_Severe-MAIT\|COVID-19_Severe / Disease condition and Cell class	RARG MATN2 NR4A2 RORA RORC	2.89e-06	177	56	5	8eb69041f482b58325e3539f607923f7b1fa5977
ToppCell	COPD-Myeloid-cDC1\|World / Disease state, Lineage and Cell class	ARHGAP5 THRB ZNF516 NR4A3 NR1H2	3.49e-06	184	56	5	42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94
ToppCell	Mild-CD4+_T\|Mild / Disease group and Cell class	RARG RORA RORC NR3C2 PPARG	3.59e-06	185	56	5	c28ecb63146de1b02418e5a4fad0ae7c2b66a41d
ToppCell	IPF-Myeloid-cDC1\|World / Disease state, Lineage and Cell class	THRB ZNF516 IRF8 NR4A3 NR1H2	3.68e-06	186	56	5	962c2dada19185628ead77c32fcb07fa95114247
ToppCell	LV-14._Fibroblast_III\|World / Chamber and Cluster_Paper	BNC2 NR4A2 NR4A3 RORA NR4A1	3.98e-06	189	56	5	3922135d1f6fc768d71ba3b465585fead6ea68a8
ToppCell	RA-14._Fibroblast_III\|World / Chamber and Cluster_Paper	BNC2 NR4A2 NR4A3 RORA NR4A1	3.98e-06	189	56	5	b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b
ToppCell	10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like\|bone_marrow / Manually curated celltypes from each tissue	PHF1 RARG MATN2 RORA RORC	3.98e-06	189	56	5	ac2995e599f3d1813218479dc515b1d612c0ef8b
ToppCell	COPD-Myeloid-cDC1\|COPD / Disease state, Lineage and Cell class	ARHGAP5 THRB ZNF516 NR4A3 NR1H2	4.30e-06	192	56	5	bd3d00b094d92463b06023361a71240851a542b8
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SNED1 BNC2 NR4A3 RORA NR4A1	4.41e-06	193	56	5	261cafc167c86ab277be4ea7f08b0173e2dde26e
ToppCell	LV-14._Fibroblast_III\|LV / Chamber and Cluster_Paper	BNC2 NR4A2 NR4A3 RORA NR4A1	4.52e-06	194	56	5	927c26aea0147f7a4b8fb3f192de4de263f1b978
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SNED1 BNC2 NR4A3 RORA NR4A1	4.64e-06	195	56	5	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-MAIT\|COVID-19_Mild / Disease, condition lineage and cell class	PHF1 RARG NR4A2 RORA RORC	5.25e-06	200	56	5	45b2a84d5a325f551205ae31c164d2de7773d3b6
ToppCell	primary_visual_cortex\|World / Per Region, Lineage, Cell class, Cell type, Cell subtype	EML5 NR4A2 IRF8 NR4A3	2.99e-05	141	56	4	605d7b28e99c943f64b4095855a6f9f70e92cb09
ToppCell	Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	NR4A2 NR4A3 NR4A1 STAC	4.44e-05	156	56	4	029ba0832ee9c4a2c85620e4df2260e02d86b45c
ToppCell	Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	NR4A2 NR4A3 NR4A1 STAC	4.44e-05	156	56	4	5df19a235843829f5a1a90ca21b0964ef8b4e115
ToppCell	facs-SCAT-Fat-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAMK2B NR4A2 IRF8 NR4A3	4.55e-05	157	56	4	ad8c6eb34f5288288c4066119c17325afefbaafc
ToppCell	Posterior_cortex\|World / BrainAtlas - Mouse McCarroll V32	THRB FEZF2 NR4A3 NR4A1	4.78e-05	159	56	4	18e9fe2efbe0bca7c3990f3b12b6f549e2c1263a
ToppCell	COVID-19_Moderate-MAIT\|COVID-19_Moderate / disease group, cell group and cell class	MATN2 RORA RORC STAC	4.78e-05	159	56	4	6d08d670c34eb6bb8ad5dad3293b3107c006236d
ToppCell	COVID-19_Moderate-MAIT\|World / disease group, cell group and cell class	MATN2 RORA RORC STAC	4.90e-05	160	56	4	bf73c5fe87c1f243edec17d7a2c30fae5e2cfd6b
ToppCell	droplet-Heart-nan-24m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PHF1 SALL1 RARG NR4A1	5.02e-05	161	56	4	eb546d5065ac506405d240f9a1f55f2122d0c368
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	FSTL4 RORA AR WDR59	5.79e-05	167	56	4	9efb9511a211d0824bb97f82c1a5860c43d2138f
ToppCell	Cerebellum-Neuronal-Inhibitory\|Cerebellum / BrainAtlas - Mouse McCarroll V32	FSTL4 RORA AR WDR59	5.79e-05	167	56	4	904c613aac3f9919a432b110bb1dcc832b5aec0a
ToppCell	10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like\|GI_small-bowel / Manually curated celltypes from each tissue	MATN2 FSTL4 RORC STAC	5.92e-05	168	56	4	d02eba7ece17edcdd47fd6b784c93910ce61090f
ToppCell	10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3\|GI_small-bowel / Manually curated celltypes from each tissue	MATN2 FSTL4 RORC STAC	6.20e-05	170	56	4	97df5ffb328196c46568975d2d97722bcc753bf5
ToppCell	Healthy/Control-MAIT\|World / Disease group and Cell class	NR4A2 NR4A3 RORA RORC	6.34e-05	171	56	4	61515114b17816a8f9ef6a57262eb9e977b6ede4
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells-ILC3\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NR4A3 RORA RORC STAC	6.34e-05	171	56	4	6ab7f103cbdbd49ef687cbb8a42ddc5517af0f7f
ToppCell	Healthy/Control-MAIT\|Healthy/Control / Disease group and Cell class	NR4A2 NR4A3 RORA RORC	6.63e-05	173	56	4	56247c1e07477a8922fe2e3950ae05e2217fd77c
ToppCell	wk_20-22-Hematologic_Lymphocytic-T_&_ILC-ILCP\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	RARG MATN2 RORC STAC	6.78e-05	174	56	4	5e6050d20a5b27640f6a200441125b8ceba123c8
ToppCell	10x5'-blood-Lymphocytic_Invariant-Inducer-like\|blood / Manually curated celltypes from each tissue	MATN2 ADAMTS18 RORA RORC	6.78e-05	174	56	4	51be6f29308c01593978cbee92114151a5916c9c
ToppCell	pdx-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	THRB PPARG HNF4A WDR59	7.09e-05	176	56	4	1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SNED1 ADAMTS18 RORA NR3C2	7.41e-05	178	56	4	51d2188406f04329311b2efd1108fc36617a860e
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4-Trm_Th1/Th17\|GI_large-bowel / Manually curated celltypes from each tissue	MATN2 RORA RORC NR4A1	7.57e-05	179	56	4	6359f30005b17dc5b5c4c8f3a6a38c87ccfe4ee9
ToppCell	facs-SCAT-Fat-3m-Lymphocytic-NK_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FSTL4 NR4A3 RORA RORC	7.57e-05	179	56	4	6f657c7a227f860934d0dfec9b97d35fd2cedfd2
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SNED1 ADAMTS18 RORA NR3C2	7.74e-05	180	56	4	cfc8bfbfd3617aabbb49f9730c29b673ca157e74
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RARG MATN2 RORA RORC	8.07e-05	182	56	4	f30e5a21b49f30b82e2b6f1fd2daefd805a40083
ToppCell	COVID-19_Severe-Lymphoid_T/NK-MAIT\|COVID-19_Severe / Disease group, lineage and cell class	RARG MATN2 RORA RORC	8.07e-05	182	56	4	19045db5c726c06ec6e4feb4311633c8164ddb3c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	RARG MATN2 RORA RORC	8.07e-05	182	56	4	cccac9f85825f4e310b86e37ee6320769a670501
ToppCell	droplet-Kidney-nan-18m-Mesenchymal-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATN2 NR3C2 LOXL3 ZFP82	8.07e-05	182	56	4	e3248d108b51c49ca2c978636e13017e23b53860
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RARG MATN2 RORA RORC	8.07e-05	182	56	4	1444cdc4522a70a40d697ccadf54cf26d327ade0
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	RARG MATN2 RORA RORC	8.07e-05	182	56	4	49eced222e8f90c2b59bcc7d56b62c3e703fcce5
ToppCell	URO-Lymphocyte-T_NK-dnT\|URO / Disease, Lineage and Cell Type	RARG RORA ZNF615 ZNF606	8.07e-05	182	56	4	f2b1c524301d0f2d1b69c46f3653fd53c21c3aa0
ToppCell	PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CACNG7 EML5 CAMK2B STAC	8.42e-05	184	56	4	571136c832cb8c08457744152231537aa8e8abd7
ToppCell	droplet-Lung-30m-Hematologic-lymphocytic-immature_innate_lymphoid_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FSTL4 RORA RORC AR	8.42e-05	184	56	4	3d8008f8d2e39c0d7a3cabc45620027491da03cf
ToppCell	droplet-Lung-30m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FSTL4 RORA RORC AR	8.42e-05	184	56	4	eeed75984ff111c0d1750df2f978163a42f20207
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_A\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	BNC2 NR4A2 FSTL4 IRF8	8.60e-05	185	56	4	25781cf68e693e97dc1885e2879ab24fa946b51e
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D231\|Adult / Lineage, Cell type, age group and donor	SNED1 BNC2 MATN2 RORA	8.60e-05	185	56	4	fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCell	Control-Myeloid-cDC1\|World / Disease state, Lineage and Cell class	ARHGAP5 THRB ZNF516 NR4A3	8.78e-05	186	56	4	3de803dee3ef10eb85a2b47d3f93385214e5b0ff
ToppCell	10x5'v1-week_12-13-Lymphocytic_T-T_NK-NK_T_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	RARG MATN2 FSTL4 RORC	8.78e-05	186	56	4	b099cb0902e9afb11218d70407d3cab212343c6d
ToppCell	Control-Myeloid-cDC1\|Control / Disease state, Lineage and Cell class	ARHGAP5 THRB NR4A3 NR4A1	8.78e-05	186	56	4	b05c394aa3573ba855abc3066739ca193883b0c3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THRB FSTL4 NR3C2 PPARG	8.96e-05	187	56	4	e3095455d2f255854f339f6b05fa87852af0700f
ToppCell	B_cells-Naive_B_cells_\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	NR4A2 IRF8 NR4A3 NR4A1	9.15e-05	188	56	4	d1bc1316bbb8cfc39acc70f8680b14d19f536997
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THRB ADAMTS18 NR3C2 PPARG	9.15e-05	188	56	4	e751cff2ac8fbc1487766c1871fcc5d1005286b0
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17\|lymph-node_spleen / Manually curated celltypes from each tissue	SP5 RORA RORC NR4A1	9.15e-05	188	56	4	a20521198c6db17589535fb439533329582c9dd2
ToppCell	IPF-Myeloid-cDC1\|IPF / Disease state, Lineage and Cell class	THRB IRF8 NR4A3 NR1H2	9.15e-05	188	56	4	2331a2bae1383820d598e93aa86c75b101069bac
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like\|lymph-node_spleen / Manually curated celltypes from each tissue	MATN2 RORA RORC STAC	9.53e-05	190	56	4	0c7eb8f4f2926af01bf44d5c9f239be7b81c67fe
ToppCell	Severe-MAIT\|World / Disease group and Cell class	THRA RARG RORA RORC	9.53e-05	190	56	4	7a92e0d6a021be23125495927b8571e25c83204a
ToppCell	BAL-Control-Lymphocyte-B-B_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SNED1 NR4A2 NR4A3 NR4A1	9.53e-05	190	56	4	da7341a8a423e5fe4d8e733d8e50c10a3318ac1c
ToppCell	BAL-Control-Lymphocyte-B-B_cell-B_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SNED1 NR4A2 NR4A3 NR4A1	9.53e-05	190	56	4	42312f7d79fe889397d32910b625793e2535cc26
ToppCell	BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SNED1 NR4A2 NR4A3 NR4A1	9.53e-05	190	56	4	682418a7a2096743112eae3790d40e7e600612c0
ToppCell	ILEUM\|World / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NR4A2 NR4A3 RORA NR4A1	9.53e-05	190	56	4	4395dbd18c14d491f5066a2ddac438a16b1fd7c3
ToppCell	Severe-MAIT\|Severe / Disease group and Cell class	THRA RARG RORA RORC	9.53e-05	190	56	4	1c063dc1b62d9f9912aaf8d0297555a6545f5550
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	NR4A2 IRF8 NR4A3 NR4A1	9.73e-05	191	56	4	a073d58154c801ec499fd969f42b7f1ee7f15d79
ToppCell	COVID-19_Mild-MAIT\|COVID-19_Mild / Disease condition and Cell class	RARG NR4A2 RORA RORC	9.73e-05	191	56	4	e834d7a6aa7bb4f194b203d351e53bf5d95175d6
ToppCell	COPD-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	ARHGAP5 THRB ZNF516 NR4A3	9.73e-05	191	56	4	3480e6d27dd4291765bbbb2acdb6a2e4f02c8085
ToppCell	10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-MAIT\|bone_marrow / Manually curated celltypes from each tissue	RARG MATN2 RORA RORC	9.73e-05	191	56	4	7a28905ad504979497836e87df81d529e675ce78
ToppCell	ILEUM-non-inflamed-(2)_B_cell-(2)_Memory_B_cells\|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NR4A2 NR4A3 RORA NR4A1	9.92e-05	192	56	4	37d0d0fdd6bc3114d546020b472b6df9392392f4
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-T_follicular_helper_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PHF1 NR4A2 NR4A3 NR1H2	9.92e-05	192	56	4	3e2a0f332e7f9833ba88f3c809cee78b65090401
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	PHF1 NR4A2 RORA RORC	9.92e-05	192	56	4	892789bdba150ef9a8a0012de52545f2ff6a31f6
ToppCell	COVID-19_Mild-Lymphoid_T/NK-MAIT\|COVID-19_Mild / Disease group, lineage and cell class	PHF1 NR4A2 RORA RORC	9.92e-05	192	56	4	d47bd132e57f5b4bddcf3dfa399cee149eca7e44
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PHF1 NR4A2 RORA RORC	9.92e-05	192	56	4	24ea8fdcca2695aeb2e4b88161184124b7d332c1
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PHF1 NR4A2 RORA RORC	9.92e-05	192	56	4	44f440ee3842fe14665c4cd4f2aa48e7a5bbd9a8
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PHF1 NR4A2 RORA RORC	9.92e-05	192	56	4	8d50ad8cfe3cb9f183188b08457756af0ce56ffe
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-D\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NR4A2 IRF8 NR4A3 NR4A1	1.01e-04	193	56	4	ed44c3192e80134d58b72f1659cd66baf16cfd86
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	BNC2 MATN2 AR STAC	1.01e-04	193	56	4	adc9fc94f9ec686a417d08c0b8b7b7ab687afec0
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	SNED1 BNC2 RORA SMC5	1.03e-04	194	56	4	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	lymphoid-NK_cell-NK_cell\|World / Lineage, cell class and subclass	BNC2 NR4A2 IRF8 RORA	1.03e-04	194	56	4	7f5adc18e632109694446b8eb1543cbae62dccbe
ToppCell	ILEUM-non-inflamed-(1)_T_cell-(1)_Cytotoxic_CD8_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NR4A2 IRF8 NR4A3 NR4A1	1.03e-04	194	56	4	094e8dfe640c7cca410b85f93063ea0bd7e861cf
ToppCell	RA\|World / Chamber and Cluster_Paper	BNC2 NR4A3 NR4A1 SMC5	1.03e-04	194	56	4	08f0afbb68a63150fbe107a5337299081c3f69e4
ToppCell	P28-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NR4A2 NR4A3 RORA NR4A1	1.03e-04	194	56	4	3c661c6768c3f05d2aba03d329adb257ca201b2d
ToppCell	Control-MAIT\|Control / Disease condition and Cell class	RARG MATN2 RORA RORC	1.03e-04	194	56	4	ed99f8bff6766795fc396990604366f49ff58181
ToppCell	P15-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NR4A2 NR4A3 RORA NR4A1	1.03e-04	194	56	4	5f04d21c4e2d36e74b6c5889aa97fd98f75a0973
ToppCell	lymphoid-NK_cell\|World / Lineage, cell class and subclass	BNC2 NR4A2 IRF8 RORA	1.03e-04	194	56	4	4bf5a140be8691e4ec99d7ee15588fd48acd6fb5
ToppCell	Mild/Remission-B_memory-0\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	PHF1 NR4A2 RORA NR1H2	1.03e-04	194	56	4	4866093b50cdf895f06b60684cc3aaa9769aa4dc
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RARG MATN2 RORA RORC	1.05e-04	195	56	4	c7b54b210cc2c8ddaefebfba74381adb2ca698b8
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	RARG MATN2 RORA RORC	1.05e-04	195	56	4	e173a713d273b135db4f71bdcaada3b0e55d74f1
ToppCell	Mild/Remission-B_memory-0\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	PHF1 NR4A2 RORA NR1H2	1.05e-04	195	56	4	3c51f005d8546c570752f5f0ce6b8ac242d3c54b
ToppCell	mild_COVID-19\|World / disease group, cell group and cell class (v2)	NR4A2 NR4A3 RORA NR4A1	1.05e-04	195	56	4	6dbe9db5f0e94f2e91b3d1282855d200051ab0ba
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NR4A2 IRF8 NR4A3 NR4A1	1.05e-04	195	56	4	d07a8cfecf7a54cf6274565b1649e735abb79c87
ToppCell	E12.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	BNC2 MATN2 ADAMTS18 NR4A1	1.05e-04	195	56	4	febe746099964b9ea9e75f2efc72c962c01f0421
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	RARG MATN2 RORA RORC	1.05e-04	195	56	4	59164d115a0928cc9b79c7661c7190ad695f9d80
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NR4A2 IRF8 NR4A3 NR4A1	1.05e-04	195	56	4	562e4c0e4e81f6303e57b846da71d1667fc35963
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MATN2 RORA RORC STAC	1.05e-04	195	56	4	d70b49f6b9c6c4422adb2936c837a1af7569fb0a
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NR4A2 IRF8 NR4A3 NR4A1	1.05e-04	195	56	4	fa8ac154e5aebc26463ff84f0ad1038095770bc6
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RARG MATN2 RORA RORC	1.05e-04	195	56	4	a8fd42ff6c2bd80d0e3f20fe3bbf7d113b399df1
Computational	Genes in the cancer module 123.	ZNF516 NR4A2 ZNF264 RORA PPARG AR	7.60e-05	247	32	6	MODULE_123
Computational	Genes in the cancer module 113.	THRB HNF4A AR NR1I3	2.69e-04	107	32	4	MODULE_113
Drug	AC1L2E0P	NR2C1 THRA THRB RARG NR4A2 NR4A3 NR1H2 NR3C2 NR4A1 PPARG HNF4A AR NR1I3	4.25e-13	307	56	13	CID000019390
Drug	AC1L9K70	NR2C1 THRA THRB RARG IRF8 RORA NR3C2 PPARG HNF4A AR NR1I3	7.99e-12	228	56	11	CID000446871
Drug	AC1L3UEY	NR2C1 THRA THRB RORA NR3C2 PPARG AR NR1I3	3.34e-10	113	56	8	CID000122342
Drug	CV-1	NR2C1 THRA THRB NR3C2 NR4A1 PPARG HNF4A AR NR1I3	2.40e-09	213	56	9	CID000130105
Drug	A25618	NR2C1 SALL2 THRA SALL1 THRB RARG ZRSR2 TM4SF5 ZNF224 NR4A1 PPARG HNF4A AR ACTR2	3.97e-09	777	56	14	CID000005562
Drug	UVI 3003	THRA THRB RARG PPARG	1.07e-08	11	56	4	ctd:C525131
Drug	tetrachlorodian	THRA THRB PPARG AR	3.22e-08	14	56	4	ctd:C041181
Drug	dalcetrapib	NR4A2 NR3C2 PPARG NR1I3	4.39e-08	15	56	4	ctd:C411602
Drug	Dichlorodiphenyl Dichloroethylene	CACNG7 THRA THRB CAMK2B NR4A2 NR4A1 PPARG AR NR1I3	4.95e-08	302	56	9	ctd:D003633
Drug	enilconazole	RARG RORA AR NR1I3	7.63e-08	17	56	4	ctd:C017435
Drug	triflumizol	RORA RORC PPARG AR	1.54e-07	20	56	4	ctd:C053549
Drug	di-n-pentyl phthalate	NR4A3 NR4A1 PPARG AR NR1I3	1.62e-07	51	56	5	ctd:C034171
Drug	Teniposide	THRA THRB NR1H2 AR	1.90e-07	21	56	4	ctd:D013713
Drug	tris(chloroethyl)phosphate	CAMK2B NR3C2 PPARG HNF4A AR	2.37e-07	55	56	5	ctd:C031324
Drug	ecdysone	NR2C1 NR2C2 NR4A2 RORA NR1H2 RORC NR4A1	2.66e-07	178	56	7	CID000019212
Drug	3,5-di-tert-butyl-4-hydroxybenzaldehyde	THRB PPARG AR	2.80e-07	6	56	3	ctd:C513957
Drug	cyclosporine A; Up 200; 1uM; MCF7; HG-U133A	ZNF264 RORC ZNF224 NR4A1 HNF4A ZNF614 STAC	4.45e-07	192	56	7	602_UP
Drug	2,2',4,4',5-brominated diphenyl ether	THRA THRB PPARG AR	4.71e-07	26	56	4	ctd:C477694
Drug	ethyl myristate	THRB PPARG AR	4.90e-07	7	56	3	ctd:C032396
Drug	triphenyl phosphate	THRA THRB NR3C2 PPARG AR NR1I3	5.20e-07	121	56	6	ctd:C005445
Drug	Uranium	NR1H2 SMC5 HNF4A AR WDR59 ACTR2 ZFP82 NR1I3	6.14e-07	296	56	8	ctd:D014501
Drug	mespirenone	NR3C2 NR4A1 AR	7.82e-07	8	56	3	CID000065660
Drug	8-Bromo Cyclic Adenosine Monophosphate	THRA RARG NR4A2 NR4A3 RORA NR1H2 NR3C2 NR4A1 PPARG AR NR1I3	8.21e-07	693	56	11	ctd:D015124
Drug	EPI 001	THRB PPARG AR	1.17e-06	9	56	3	ctd:C551471
Drug	monoisononylphthalate	NR1H2 PPARG NR1I3	1.17e-06	9	56	3	ctd:C471400
Drug	diisobutyl phthalate	THRB PPARG AR NR1I3	1.27e-06	33	56	4	ctd:C025605
Drug	mono-benzyl phthalate	PPARG AR NR1I3	1.67e-06	10	56	3	ctd:C103325
Drug	Thiazolidinediones	THRA THRB PPARG	1.67e-06	10	56	3	ctd:D045162
Drug	ethofenprox	THRB AR NR1I3	2.29e-06	11	56	3	ctd:C076840
Drug	pazopanib	THRA THRB AR	3.05e-06	12	56	3	ctd:C516667
Drug	Proscillaridin A [466-06-8]; Up 200; 7.6uM; HL60; HT_HG-U133A	PHF1 NR2C2 CAMK2B NR4A2 NR4A3 NR4A1	3.07e-06	164	56	6	2920_UP
Drug	Chlordan	RARG RORA RORC AR NR1I3	3.48e-06	94	56	5	ctd:D002706
Drug	Polybrominated Biphenyls	THRA THRB AR	3.96e-06	13	56	3	ctd:D011075
Drug	fenvalerate	THRA THRB NR3C2 AR NR1I3	4.07e-06	97	56	5	ctd:C017690
Drug	2,2',4,4'-tetrahydroxybenzophenone	THRA THRB NR4A1	5.03e-06	14	56	3	ctd:C035476
Drug	Spironolactone	NR3C2 AR	5.94e-06	2	56	2	DB00421
Drug	Levothyroxine	THRA THRB	5.94e-06	2	56	2	DB00451
Drug	Liothyronine	THRA THRB	5.94e-06	2	56	2	DB00279
Drug	Liotrix	THRA THRB	5.94e-06	2	56	2	DB01583
Drug	2,3,4',6-tetrachlorobiphenyl	AR NR1I3	5.94e-06	2	56	2	ctd:C052915
Drug	2,3,5,6-tetrachlorobiphenyl	AR NR1I3	5.94e-06	2	56	2	ctd:C078132
Drug	spirorenone	NR3C2 AR	5.94e-06	2	56	2	CID000068923
Drug	2,4,6-trichlorobiphenyl	AR NR1I3	5.94e-06	2	56	2	ctd:C102834
Drug	3,3,5-trimethylcyclohexanone	THRB PPARG	5.94e-06	2	56	2	ctd:C438457
Drug	2,3',4,4'-tetrachlorobiphenyl	AR NR1I3	5.94e-06	2	56	2	ctd:C054482
Drug	prorenoate	NR3C2 AR	5.94e-06	2	56	2	CID000162581
Drug	AC1L2X7C	NR3C2 NR4A1	5.94e-06	2	56	2	CID000104633
Drug	Irganox 1010	THRB PPARG	5.94e-06	2	56	2	ctd:C045762
Drug	tosyl azide	NR3C2 NR4A1	5.94e-06	2	56	2	CID000013661
Drug	3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid	THRA THRB	5.94e-06	2	56	2	DB03176
Drug	KB 130015	THRA THRB	5.94e-06	2	56	2	ctd:C446946
Drug	Rafoxanide	THRA THRB	5.94e-06	2	56	2	ctd:D011888
Drug	4-vinylcyclohexene diepoxide	NR2C1 THRA THRB RARG PPARG	6.00e-06	105	56	5	CID000007833
Drug	TO-901317	RORA NR1H2 RORC PPARG NR1I3	6.29e-06	106	56	5	ctd:C423915
Drug	butylbenzyl phthalate	THRB NR4A3 PPARG AR NR1I3	6.89e-06	108	56	5	ctd:C027561
Drug	E-guggulsterone	NR2C2 NR1H2 NR3C2 PPARG AR	6.89e-06	108	56	5	CID006439929
Drug	Chlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; MCF7; HT_HG-U133A	THRA THRB NR4A2 IRF8 NR4A3 NR4A1	7.38e-06	191	56	6	2627_UP
Drug	1q4x	NR2C1 THRA THRB	7.72e-06	16	56	3	CID000448011
Drug	Nitrocaramiphen hydrochloride; Up 200; 10.8uM; MCF7; HT_HG-U133A	RARG CAMK2B NR3C2 ZNF224 AR WDR59	8.56e-06	196	56	6	6504_UP
Drug	Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; HL60; HG-U133A	BNC2 SALL2 NR4A1 SMC5 ZNF614 STAC	8.56e-06	196	56	6	2036_UP
Drug	Altretamine [654-05-6]; Down 200; 19uM; PC3; HT_HG-U133A	ZXDC SNED1 NR2C1 THRA ZNF224 WDR59	9.07e-06	198	56	6	4627_DN
Drug	Dicofol	THRA THRB AR	9.35e-06	17	56	3	ctd:D004010
Drug	SR-202	NR4A2 NR4A1 PPARG	9.35e-06	17	56	3	CID000060910
Drug	1,1-bis(4-hydroxyphenyl)cyclohexane	THRA THRB NR1I3	9.35e-06	17	56	3	ctd:C517113
Drug	Methimazole	PHF1 SNED1 THRA THRB CAMK2B NR4A2 NR3C2 PPARG	1.11e-05	438	56	8	ctd:D008713
Drug	tribromodiphenyl ether 28	THRA THRB AR	1.12e-05	18	56	3	ctd:C533760
Drug	HX600	RARG NR4A2 PPARG	1.12e-05	18	56	3	CID000128016
Drug	Endosulfan	NR2C1 RARG CAMK2B RORC ZNF224 PPARG AR NR1I3	1.29e-05	447	56	8	ctd:D004726
Drug	3-acetyldeoxynivalenol	THRB PPARG AR	1.33e-05	19	56	3	ctd:C043247
Drug	anacetrapib	NR4A2 NR3C2 PPARG	1.33e-05	19	56	3	ctd:C530884
Drug	cyhalothrin	THRB CAMK2B PPARG AR	1.35e-05	59	56	4	ctd:C037304
Drug	Dextrothyroxine	THRA THRB	1.78e-05	3	56	2	DB00509
Drug	2,4,6-triiodophenol	THRA PPARG	1.78e-05	3	56	2	ctd:C066859
Drug	2,4'-dichlorobiphenyl	AR NR1I3	1.78e-05	3	56	2	ctd:C029907
Drug	3,4-dimethylbenzaldehyde	THRB PPARG	1.78e-05	3	56	2	ctd:C476925
Drug	Drospirenone	NR3C2 AR	1.78e-05	3	56	2	DB01395
Drug	2,3-dichlorobiphenyl	AR NR1I3	1.78e-05	3	56	2	ctd:C030375
Drug	Fludrocortisone	NR3C2 AR	1.78e-05	3	56	2	DB00687
Drug	tetrahydrogestrinone	AR NR1I3	1.78e-05	3	56	2	ctd:C479553
Drug	mexrenone	NR3C2 AR	1.78e-05	3	56	2	CID003082529
Drug	Bithionol	THRA THRB	1.78e-05	3	56	2	ctd:D001735
Drug	2-chlorobiphenyl	AR NR1I3	1.78e-05	3	56	2	ctd:C055142
Drug	butyl diglycol acetate	THRB PPARG	1.78e-05	3	56	2	ctd:C061482
Drug	DB04680	NR2C1 THRA THRB MATN2 HNF4A NR1I3	1.87e-05	225	56	6	CID005326972
Drug	perchlorate	THRA THRB CAMK2B NR3C2 PPARG	1.90e-05	133	56	5	ctd:C494474
Drug	di-n-hexyl phthalate	PPARG AR NR1I3	2.10e-05	22	56	3	ctd:C027387
Drug	bisphenol B	THRA THRB AR	2.10e-05	22	56	3	ctd:C492482
Drug	2,2-bis(4-glycidyloxyphenyl)propane	NR4A1 PPARG AR NR1I3	2.38e-05	68	56	4	ctd:C019273
Drug	NOR-1	NR4A2 NR4A3 NR3C2 NR4A1	2.67e-05	70	56	4	CID006399012
Drug	Permethrin	THRB NR4A2 NR4A3 PPARG AR NR1I3	2.69e-05	240	56	6	ctd:D026023
Drug	DITPA	NR2C1 THRA THRB	2.75e-05	24	56	3	CID000160565
Drug	Antigen-Antibody Complex	NR4A2 NR4A3 NR4A1	2.75e-05	24	56	3	ctd:D000936
Drug	Thyroxine	THRA THRB NR3C2 PPARG NR1I3	3.07e-05	147	56	5	ctd:D013974
Drug	exoenzyme C3, Clostridium botulinum	NR4A2 NR4A3 PPARG	3.12e-05	25	56	3	ctd:C063007
Drug	dicyclohexyl phthalate	ARHGAP5 NR2C2 THRA THRB NR4A3 NR1H2 PPARG AR ACTR2 NR1I3	3.25e-05	836	56	10	ctd:C036042
Drug	Prt-H	NR2C1 THRA THRB	3.52e-05	26	56	3	CID003050291
Drug	Gonadotropins, Equine	NR4A1 PPARG AR	3.52e-05	26	56	3	ctd:D006064
Drug	KB-141	THRA THRB	3.55e-05	4	56	2	CID009863447
Drug	2,6-diisopropylnaphthalene	THRB PPARG	3.55e-05	4	56	2	ctd:C018520
Drug	2,5,3'-trichlorobiphenyl	AR NR1I3	3.55e-05	4	56	2	ctd:C091160
Disease	Insulin Sensitivity	NR4A3 NR4A1 PPARG AR	4.53e-06	60	54	4	C0920563
Disease	Insulin Resistance	NR4A3 NR4A1 PPARG AR	4.53e-06	60	54	4	C0021655
Disease	thyroid hormone resistance syndrome (implicated_via_orthology)	THRA THRB	9.85e-06	3	54	2	DOID:11633 (implicated_via_orthology)
Disease	Endometrioma	NR2C1 NR2C2 THRA NR3C2 NR4A1	1.16e-05	161	54	5	C0269102
Disease	Endometriosis	NR2C1 NR2C2 THRA NR3C2 NR4A1	1.16e-05	161	54	5	C0014175
Disease	Generalized Thyroid Hormone Resistance	THRA THRB	1.97e-05	4	54	2	C4722330
Disease	arterial stiffness measurement	BNC2 PPARG STAC	2.23e-04	64	54	3	EFO_0004517
Disease	serum gamma-glutamyl transferase measurement	SALL1 THRB TM4SF5 RORA RORC PPARG HNF4A NR1I3	2.42e-04	914	54	8	EFO_0004532
Disease	skin pigmentation	BNC2 RORA HERC2	2.79e-04	69	54	3	EFO_0003784
Disease	actinic keratosis	BNC2 HERC2	2.95e-04	14	54	2	EFO_0002496
Disease	Monogenic diabetes	PPARG HNF4A	3.88e-04	16	54	2	C3888631
Disease	Pseudopelade	PPARG AR	5.51e-04	19	54	2	C0086873
Disease	obesity (is_implicated_in)	NR1H2 PPARG AR	6.28e-04	91	54	3	DOID:9970 (is_implicated_in)
Disease	subcutaneous adipose tissue measurement	RORA NR3C2 STAC	6.69e-04	93	54	3	EFO_0004766
Disease	suntan	BNC2 ZNF341 HERC2	9.00e-04	103	54	3	EFO_0004279
Disease	urate measurement, bone density	NR2C2 SALL2 SALL1 FEZF1 ZNF516 NR3C2	9.14e-04	619	54	6	EFO_0003923, EFO_0004531
Disease	TYPE 2 DIABETES MELLITUS	PPARG HNF4A	1.21e-03	28	54	2	125853
Disease	Type 2 diabetes mellitus	PPARG HNF4A	1.21e-03	28	54	2	cv:C0011860
Disease	blood vanadium measurement	THRB RORA	1.38e-03	30	54	2	EFO_0021533
Disease	corneal resistance factor	ZNF516 ADAMTS18 NR3C2 HERC2 SMC5	1.39e-03	451	54	5	EFO_0010067
Disease	non-melanoma skin carcinoma	BNC2 ZNF341 RORC HERC2	1.41e-03	265	54	4	EFO_0009260
Disease	total cholesterol measurement, C-reactive protein measurement	RORA HNF4A	1.48e-03	31	54	2	EFO_0004458, EFO_0004574
Disease	Diabetes Mellitus	PPARG NR1I3	1.57e-03	32	54	2	C0011849
Disease	vital capacity	BNC2 RARG ZNF337 ZNF341 CAMK2B ADAMTS18 RORA ZFP82	1.74e-03	1236	54	8	EFO_0004312
Disease	primary dental caries	FSTL4 ADAMTS18	1.78e-03	34	54	2	EFO_0600095

Protein segments in the cluster

Peptide	Gene	Start	Entry
SRKGRVFCNACGKTF	BNC2	436	Q6ZN30
RKVVVCDNGTGFVKC	ACTR2	6	P61160
SQCSKTCGRGVRKRE	ADAMTS18	1001	Q8TE60
GAVTCEGCKGFFKRS	NR2C1	126	P13056
AVSCEGCKGFFKRSV	NR2C2	131	P49116
SCEGCKGFFRRSIQK	RARG	106	P13631
VRTCEGCKGFFKRTV	NR4A1	281	P22736
LTCEGCKGFFRRTVS	NR1I3	26	Q14994
CKRTGTRFTAGVICS	LOXL3	511	P58215
GVVTCGSCKVFFKRA	NR3C2	616	P08235
GFVLAEDGRRCKKCT	MATN2	636	O00339
SAVFCGRSGKQLKRC	HERC2	2756	O95714
SCDGCKGFFRRSVRK	HNF4A	76	P41235
GVFVKRLCQGRVFCS	IRF8	286	Q02556
TCGSCKVFFKRAAEG	AR	576	P10275
GKKFCSRGSRCVLSR	FSTL4	66	Q6MZW2
VCFFAGREKGRCVAS	CACNG7	61	P62955
QATDCVRSVCRGKGK	EML5	1651	Q05BV3
ERPFKCKICGRAFTT	SALL1	731	Q9NSC2
ERPFKCKVCGRAFST	SALL2	656	Q9Y467
VCKVCGKGFRQASTL	FEZF2	306	Q8TBJ5
CRQCVFAIATKRGGA	PHF1	136	O43189
GVRTCEGCKGFFKRT	NR4A2	276	P43354
VRTCEGCKGFFKRTV	NR4A3	306	Q92570
GKGAFSVVRRCVKLC	CAMK2B	21	Q13554
TGEKRFACPECGKRF	SP5	351	Q6BEB4
KVCGKGFRQASTLCR	FEZF1	291	A0PJY2
VLSCEGCKGFFRRSV	NR1H2	101	P55055
CEGCKGFFRRTIRLK	PPARG	156	P37231
GVGKSCLCNRFVRSK	ARHGAP5	31	Q13017
GFKGRRCELACIKVS	SNED1	1336	Q8TER0
CSECGKGFIEKRRLT	ZNF615	346	Q8N8J6
QGKSSECFECGKIFR	ZNF516	511	Q92618
GGRFKCQVCKKFFRR	ZNF341	591	Q9BYN7
TRFVRGTCKKTDGTC	ZC3H3	701	Q8IXZ2
RCGECGKAFTRKDTL	ZNF671	286	Q8TAW3
RRFTCPVEGCGKSFT	ZXDC	386	Q2QGD7
ITCEGCKGFFRRSQR	RORC	46	P51449
GVITCEGCKGFFRRS	RORA	86	P35398
EKIFRCVRTFIGCKE	STAC	346	Q99469
CITCEGCKGFFRRTI	THRB	121	P10828
PFKCVECGKGFSRRS	ZNF234	231	Q14588
RSEVRGTQCAICKGF	WDR59	906	Q6PJI9
GEKSLTCVERGKGFC	ZNF226	276	Q9NYT6
GEKSFVCTECGQVFR	ZNF264	311	O43296
CKECGKAFRVRGQLT	ZFP82	256	Q8N141
RCITCEGCKGFFRRT	THRA	66	P10827
SKTGACRFGDRCSRK	ZRSR2P1	181	Q15695
PFVCTECGRGFTRKS	ZNF875	496	P10072
TIGVFCGDCRKKQDT	TM4SF5	181	O14894
CSECGKGFTVKRTLV	ZNF614	401	Q8N883
PFKCVECGKGFSRRS	ZNF224	231	Q9NZL3
RADKVGFFVKRGCSR	SMC5	106	Q8IY18
SKTGACRFGDRCSRK	ZRSR2	176	Q15696
EKRFICSECGKAFSG	ZNF606	761	Q8WXB4
VCKDCGRGFIQKSTF	ZNF337	461	Q9Y3M9